# locus	type	ref	length	genotype	filter	pvalue	phred_qual_score	cnv_pvalue	coverage	allele_coverage	allele_ratio	allele_frequency_%	allele_frequency_%_corrected	zygosity	entry_count	maf	hrun	som_pval	gene	transcript	location	function	codon	exon	protein	coding	sift	polyphen	grantham	normalizedAlt	5000Exomes	FATHMM	NamedVariants	clinvar	cosmic	dbsnp	dgv	dra	drugbank	go	omim	pfam	phylop	dra_20170914	GRCh38_clinvar_20201226	GRCh38_cosmic_92	GRCh38_dbsnp_154	GRCh38_dgv_20200225	GRCh38_drugbank_20201029	GRCh38_esp6500_20151203	GRCh38_go_20201118	GRCh38_namedVariants_20151113	GRCh38_omim_20201202	GRCh38_pfam_33	GRCh38_phylop_20151118	GRCh38_refgene_201	gender	MyVariantDefaultDb_GRCh38
chr1:11790870	SNV	C	1	C/T	PASS	6.409143566447698e-81	801.932		400	C=211,T=189	C=0.5275,T=0.4725	47.25	52.75	heterozygous	1	0.074	2		MTHFR	NM_005957.5	MTHFR:exonic:NM_005957.5	missense	CAG	12	p.Arg594Gln	c.1781G>A	1.0	0.0	43.0	T	GMAF=0.0406:AMAF=0.0297:EMAF=0.0462	0.07		Benign, other	4986586	rs2274976		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		3.2														M	
chr1:11790946	SNV	G	1	G/C	PASS	7.888601176185645e-71	701.03		400	G=222,C=178	G=0.555,C=0.445	44.50	55.5	heterozygous	1	0.246	1		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1753-48C>G				C	GMAF=0.2298:AMAF=0.1543:EMAF=0.2685					rs576853093:rs1332110504:rs3818762:rs1491370932		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-2.26														M	
chr1:11791061	SNV	A	1	G/G	PASS	0.0	3703.89		372	A=0,G=372	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.098	1		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1752+146T>C				G						rs7518348		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		0.08														M	
chr1:11792243	SNV	C	1	C/T	PASS	2.089296130854075e-109	1086.8		399	C=181,T=218	C=0.4536,T=0.5464	54.64	45.36	heterozygous	1	0.251	2		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1632+35G>A				T	GMAF=0.2229:AMAF=0.1491:EMAF=0.2607					rs1476413		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-1.12														M	
chr1:11794400	SNV	G	1	A/A	PASS	0.0	3845.34		386	G=0,A=386	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.097	1		MTHFR	NM_005957.5	MTHFR:exonic:NM_005957.5	synonymous	TTT	8	p.Phe435=	c.1305C>T				A	GMAF=0.1095:AMAF=0.3173:EMAF=0.003			Benign		rs756018487:rs4846051		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		0.65														M	
chr1:11794698	SNV	G	1	A/A	PASS	0.0	4003.2		400	G=0,A=400	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.421	1		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1166+31C>T				A	GMAF=0.4642:AMAF=0.4346:EMAF=0.4124					rs1994798		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-4.42														M	
chr1:23808231	SNV	T	1	C/C	PASS	0.0	3967.76		400	T=1,C=399	T=0.0025,C=0.9975	99.75	0.25	homozygous	1	0.113	1		HMGCL	NM_000191.3	HMGCL:exonic:NM_000191.3	synonymous	CTG	7	p.Leu218=	c.654A>G				C	GMAF=0.0737:AMAF=0.039:EMAF=0.0915			Benign		rs719400		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HMGCL)(dui:NBS2;dis:Core Conditions;g:HMGCL)(dui:NBS9;dis:Organic Acid Condition;g:HMGCL)(dui:NBS46;dis:3-Hydroxy-3-methylglutaric aciduria;g:HMGCL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:HMGCL)(dui:D008659;dis:Metabolic Diseases;g:HMGCL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HMGCL)(dui:D030342;dis:Genetic Diseases, Inborn;g:HMGCL)(dui:D008661;dis:Metabolism, Inborn Errors;g:HMGCL)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:HMGCL)	3-hydroxyglutaric acid	GO:0005198:GO:0006552:GO:0042594:GO:0007584:GO:0005782:GO:0046951:GO:0007005:GO:0000287:GO:0006637:GO:0031406:GO:0005777:GO:0006625:GO:0000062:GO:0005759:GO:0046872:GO:0001889:GO:0004419:GO:0005739:GO:0006629:GO:0005829:GO:0030145:GO:0032991:GO:0070542	613898	PF00682	1.23														M	
chr1:23817442	SNV	A	1	G/G	PASS	0.0	3904.88		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.112	1		HMGCL	NM_000191.3	HMGCL:intronic:NM_000191.3	unknown			p.?	c.252+34T>C				G	GMAF=0.0735:AMAF=0.039:EMAF=0.0912			Benign		rs2076344		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HMGCL)(dui:NBS2;dis:Core Conditions;g:HMGCL)(dui:NBS9;dis:Organic Acid Condition;g:HMGCL)(dui:NBS46;dis:3-Hydroxy-3-methylglutaric aciduria;g:HMGCL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:HMGCL)(dui:D008659;dis:Metabolic Diseases;g:HMGCL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HMGCL)(dui:D030342;dis:Genetic Diseases, Inborn;g:HMGCL)(dui:D008661;dis:Metabolism, Inborn Errors;g:HMGCL)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:HMGCL)	3-hydroxyglutaric acid	GO:0005198:GO:0006552:GO:0042594:GO:0007584:GO:0005782:GO:0046951:GO:0007005:GO:0000287:GO:0006637:GO:0031406:GO:0005777:GO:0006625:GO:0000062:GO:0005759:GO:0046872:GO:0001889:GO:0004419:GO:0005739:GO:0006629:GO:0005829:GO:0030145:GO:0032991:GO:0070542	613898	PF00682	-1.17														M	
chr1:45508256	SNV	G	1	G/A	PASS	6.489332095341546e-75	741.878		400	G=217,A=183	G=0.5425,A=0.4575	45.75	54.25	heterozygous	1	0.475	1		MMACHC	NM_015506.3	MMACHC:exonic:NM_015506.3	synonymous	GTA	3	p.Val107=	c.321G>A				A	GMAF=0.4162:AMAF=0.3723:EMAF=0.437	0.12		Benign	6288212	rs2275276		(dui:NBS9;dis:Organic Acid Condition;g:MMACHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMACHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMACHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMACHC)(dui:NBS2;dis:Core Conditions;g:MMACHC)(dui:NBS57;dis:Homocystinuria;g:MMACHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMACHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMACHC)(dui:D008659;dis:Metabolic Diseases;g:MMACHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMACHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMACHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMACHC)(dui:D009748;dis:Nutrition Disorders;g:MMACHC)(dui:D044342;dis:Malnutrition;g:MMACHC)(dui:D003677;dis:Deficiency Diseases;g:MMACHC)(dui:D020138;dis:Hyperhomocysteinemia;g:MMACHC)(dui:D001361;dis:Avitaminosis;g:MMACHC)(dui:D014804;dis:Vitamin B Deficiency;g:MMACHC)(dui:D009422;dis:Nervous System Diseases;g:MMACHC)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MMACHC)(dui:D002493;dis:Central Nervous System Diseases;g:MMACHC)(dui:D003240;dis:Connective Tissue Diseases;g:MMACHC)(dui:D001927;dis:Brain Diseases;g:MMACHC)(dui:D001928;dis:Brain Diseases, Metabolic;g:MMACHC)(dui:D006712;dis:Homocystinuria;g:MMACHC)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MMACHC)(dui:D014806;dis:Vitamin B 12 Deficiency;g:MMACHC)(dui:D005128;dis:Eye Diseases;g:MMACHC)(dui:D012164;dis:Retinal Diseases;g:MMACHC)(dui:D012162;dis:Retinal Degeneration;g:MMACHC)(dui:D008268;dis:Macular Degeneration;g:MMACHC)	Hydroxocobalamin:Cyanocobalamin	GO:0071949:GO:0042803:GO:0032451:GO:0009235:GO:0005515:GO:0043295:GO:0005737:GO:0016491:GO:0006749:GO:0031419:GO:0005829:GO:0055114:GO:0016740:GO:0070988:GO:0033787	609831	PF16690	-0.88														M	
chr1:75728544	INDEL	GT	1	G/G	PASS	8.433347577643619e-266	2650.74		396	GT=0,G=396	GT=0.0,G=1.0	100.00	0.0	homozygous	1	0.0	4		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.118+57delT				G				Benign		rs1454388372:rs75993895:rs1173791164:rs796117827		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	0.2,0.0														M	
chr1:75728621	SNV	A	1	G/G	PASS	0.0	3906.55		400	A=3,G=397	A=0.0075,G=0.9925	99.25	0.75	homozygous	1	0.104	2		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.118+133A>G				G						rs1146572		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	-0.18														M	
chr1:100206504	SNV	T	1	C/C	PASS	0.0	3990.8		399	T=0,C=399	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.108	1		DBT	NM_001918.5	DBT:exonic:NM_001918.5	missense	GGT	9	p.Ser384Gly	c.1150A>G	1.0	0.0	56.0	C	GMAF=0.1408:AMAF=0.2251:EMAF=0.0976			Benign		rs12021720		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:DBT)(dui:NBS2;dis:Core Conditions;g:DBT)(dui:NBS11;dis:Amino Acid Disorder;g:DBT)(dui:NBS56;dis:Maple syrup urine disease;g:DBT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:DBT)(dui:D009422;dis:Nervous System Diseases;g:DBT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:DBT)(dui:D002493;dis:Central Nervous System Diseases;g:DBT)(dui:D008659;dis:Metabolic Diseases;g:DBT)(dui:D030342;dis:Genetic Diseases, Inborn;g:DBT)(dui:D001927;dis:Brain Diseases;g:DBT)(dui:D001928;dis:Brain Diseases, Metabolic;g:DBT)(dui:D008661;dis:Metabolism, Inborn Errors;g:DBT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:DBT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:DBT)(dui:D008375;dis:Maple Syrup Urine Disease;g:DBT)		GO:0009083:GO:0031405:GO:0031625:GO:0005947:GO:0016407:GO:0005737:GO:0005759:GO:0005739:GO:0043754:GO:0042645	248610	PF02817:PF00198:PF00364	1.94														M	
chr1:100216031	SNV	A	1	A/G	PASS	3.4673685045252533e-87	864.6		397	A=202,G=195	A=0.5088,G=0.4912	49.12	50.88	heterozygous	1	0.003	1		DBT	NM_001918.5	DBT:exonic:NM_001918.5	missense	CCA	6	p.Ser242Pro	c.724T>C	0.02	0.002	74.0	G	GMAF=0.0072:AMAF=0.0011:EMAF=0.0103			Benign/Likely benign		rs146249007		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:DBT)(dui:NBS2;dis:Core Conditions;g:DBT)(dui:NBS11;dis:Amino Acid Disorder;g:DBT)(dui:NBS56;dis:Maple syrup urine disease;g:DBT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:DBT)(dui:D009422;dis:Nervous System Diseases;g:DBT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:DBT)(dui:D002493;dis:Central Nervous System Diseases;g:DBT)(dui:D008659;dis:Metabolic Diseases;g:DBT)(dui:D030342;dis:Genetic Diseases, Inborn;g:DBT)(dui:D001927;dis:Brain Diseases;g:DBT)(dui:D001928;dis:Brain Diseases, Metabolic;g:DBT)(dui:D008661;dis:Metabolism, Inborn Errors;g:DBT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:DBT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:DBT)(dui:D008375;dis:Maple Syrup Urine Disease;g:DBT)		GO:0009083:GO:0031405:GO:0031625:GO:0005947:GO:0016407:GO:0005737:GO:0005759:GO:0005739:GO:0043754:GO:0042645	248610	PF02817:PF00198:PF00364	0.9														M	
chr1:100235416	INDEL	C	1	C/CT	PASS	0.00010563066161719842	39.7621		388	C=264,CT=124	C=0.6804,CT=0.3196	31.96	68.03999999999999	heterozygous	1	0.003	6		DBT	NM_001918.5	DBT:intronic:NM_001918.5	unknown			p.?	c.251+19_251+20insA				CT	GMAF=0.0077:AMAF=0.0014:EMAF=0.0109			Benign/Likely benign		rs1557958683:rs201469612		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:DBT)(dui:NBS2;dis:Core Conditions;g:DBT)(dui:NBS11;dis:Amino Acid Disorder;g:DBT)(dui:NBS56;dis:Maple syrup urine disease;g:DBT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:DBT)(dui:D009422;dis:Nervous System Diseases;g:DBT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:DBT)(dui:D002493;dis:Central Nervous System Diseases;g:DBT)(dui:D008659;dis:Metabolic Diseases;g:DBT)(dui:D030342;dis:Genetic Diseases, Inborn;g:DBT)(dui:D001927;dis:Brain Diseases;g:DBT)(dui:D001928;dis:Brain Diseases, Metabolic;g:DBT)(dui:D008661;dis:Metabolism, Inborn Errors;g:DBT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:DBT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:DBT)(dui:D008375;dis:Maple Syrup Urine Disease;g:DBT)		GO:0009083:GO:0031405:GO:0031625:GO:0005947:GO:0016407:GO:0005737:GO:0005759:GO:0005739:GO:0043754:GO:0042645	248610	PF02817:PF00198:PF00364	-1.3														M	
chr1:115033402	SNV	A	1	G/G	PASS	0.0	4003.22		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.016	1		TSHB	NM_000549.5	TSHB:exonic:NM_000549.5	missense	GCA	2	p.Thr14Ala	c.40A>G	0.32	0.0	58.0	G	GMAF=0.0248:AMAF=0.0057:EMAF=0.0345			Benign		rs10776792		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TSHB)(dui:NBS2;dis:Core Conditions;g:TSHB)(dui:NBS12;dis:Endocrine Disorder;g:TSHB)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TSHB)(dui:D004700;dis:Endocrine System Diseases;g:TSHB)(dui:D013959;dis:Thyroid Diseases;g:TSHB)(dui:D007037;dis:Hypothyroidism;g:TSHB)(dui:D009140;dis:Musculoskeletal Diseases;g:TSHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TSHB)(dui:D001847;dis:Bone Diseases;g:TSHB)(dui:D001849;dis:Bone Diseases, Endocrine;g:TSHB)(dui:D004392;dis:Dwarfism;g:TSHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:TSHB)(dui:D001848;dis:Bone Diseases, Developmental;g:TSHB)(dui:D003409;dis:Congenital Hypothyroidism;g:TSHB)(dui:D009422;dis:Nervous System Diseases;g:TSHB)(dui:D001523;dis:Mental Disorders;g:TSHB)(dui:D000068105;dis:Bipolar and Related Disorders;g:TSHB)(dui:D009461;dis:Neurologic Manifestations;g:TSHB)(dui:D001714;dis:Bipolar Disorder;g:TSHB)(dui:D019954;dis:Neurobehavioral Manifestations;g:TSHB)(dui:D003244;dis:Consciousness Disorders;g:TSHB)(dui:D014474;dis:Unconsciousness;g:TSHB)(dui:D003128;dis:Coma;g:TSHB)		GO:0005615:GO:0043627:GO:0007186:GO:0005737:GO:0051592:GO:0007267:GO:0009653:GO:0016486:GO:0033189:GO:0005576:GO:0005179:GO:0009755	188540		0.21														M	
chr2:1423168	SNV	G	1	G/T	PASS	3.2210687912834025e-104	1034.92		399	G=186,T=213	G=0.4662,T=0.5338	53.38	46.62	heterozygous	1	0.054	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.179+39G>T				T	GMAF=0.0123:AMAF=0.0343:EMAF=0.001					rs28909374		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-4.09														M	
chr2:1433391	SNV	A	1	C/C	PASS	0.0	3981.24		398	A=0,C=398	A=0.0,C=1.0	100.00	0.0	homozygous	1	0.399	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.180-47A>C				C	GMAF=0.3166:AMAF=0.4721:EMAF=0.237					rs1473936		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-1.5														M	
chr2:1433432	SNV	C	1	C/A	PASS	2.831391995799367e-75	745.48		397	C=215,A=182	C=0.5416,A=0.4584	45.84	54.16	heterozygous	1	0.05	2		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.180-6C>A				A	GMAF=0.0073:AMAF=0.0195:EMAF=0.001	0.06		Benign	4001203	rs78253418		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.98														M	
chr2:1456034	SNV	A	1	G/G	PASS	0.0	3988.07		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.065	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.613-42A>G				G	GMAF=0.0716:AMAF=0.104:EMAF=0.055					rs4927610:rs1036271161		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.86														M	
chr2:1456232	SNV	G	1	G/T	PASS	3.6669078820369984e-98	974.357		399	G=192,T=207	G=0.4812,T=0.5188	51.88	48.12	heterozygous	1	0.365	4		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	TCT	7	p.Ala257Ser	c.769G>T	0.13	0.056	99.0	T	GMAF=0.3813:AMAF=0.3761:EMAF=0.384	0.1		Benign	7302182	rs4927611		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.75														M	
chr2:1456368	SNV	A	1	A/G	PASS	3.971001032638911e-65	644.011		291	A=147,G=144	A=0.5052,G=0.4948	49.48	50.52	heterozygous	1	0.363	3		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.819+86A>G				G	GMAF=0.3765:AMAF=0.3656:EMAF=0.3812					rs4927612		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.09														M	
chr2:1477459	SNV	G	1	G/C	PASS	4.434044016334401e-91	903.532		400	G=200,C=200	G=0.5,C=0.5	50.00	50.0	heterozygous	1	0.29	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	ACC	8	p.Ser398Thr	c.1193G>C	0.05	0.999	58.0	C	GMAF=0.2184:AMAF=0.1362:EMAF=0.2602	0.89		Benign	1579950	rs2175977		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	1.05														M	
chr2:1484896	SNV	T	1	C/C	PASS	5.675446054085721e-261	2602.46		299	T=15,C=284	T=0.0502,C=0.9498	94.98	5.019999999999996	homozygous	1	0.403	2		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.1597+42T>C				C	GMAF=0.4494:AMAF=0.3093:EMAF=0.4789					rs6715129		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.34														M	
chr2:1487951	SNV	G	1	G/A	PASS	5.615649583575207e-83	822.506		399	G=208,A=191	G=0.5213,A=0.4787	47.87	52.13	heterozygous	1	0.043	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	synonymous	GCA	10	p.Ala576=	c.1728G>A				A	GMAF=0.0049:AMAF=0.0016:EMAF=0.0066	0.02		Benign	148792	rs78406347		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-5.25														M	
chr2:1494031	SNV	C	1	C/T	PASS	3.3900023557562343e-99	984.698		399	C=191,T=208	C=0.4787,T=0.5213	52.13	47.87	heterozygous	1	0.359	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	synonymous	GAT	11	p.Asp666=	c.1998C>T				T	GMAF=0.3505:AMAF=0.3221:EMAF=0.3651	0.01		Benign	3757660	rs780537993:rs1126797		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-5.14														M	
chr2:1494059	SNV	G	1	G/A	PASS	2.723955447120832e-88	875.648		400	G=203,A=197	G=0.5075,A=0.4925	49.25	50.75	heterozygous	1	0.125	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.2006+20G>A				A	GMAF=0.0928:AMAF=0.1963:EMAF=0.0398			Benign		rs10189329		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-1.97														M	
chr2:1495956	SNV	C	1	C/T	PASS	2.276145393141675e-87	866.428		400	C=204,T=196	C=0.51,T=0.49	49.00	51.0	heterozygous	1	0.273	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.2007-33C>T				T	GMAF=0.2825:AMAF=0.2245:EMAF=0.3123					rs2276704		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.1														M	
chr2:1496127	SNV	C	1	C/T	PASS	5.262595620803134e-77	762.788		246	C=103,T=143	C=0.4187,T=0.5813	58.13	41.87	heterozygous	1	0.439	4		TPO	NM_000547.5	TPO:exonic:NM_000547.5	synonymous	CCT	12	p.Pro715=	c.2145C>T				T	GMAF=0.413:AMAF=0.4414:EMAF=0.3985	0.04		Benign	1685440	rs732608		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-2.72														M	
chr2:1496155	SNV	A	1	A/C	PASS	2.023951027988788e-79	786.938		240	A=97,C=143	A=0.4042,C=0.5958	59.58	40.42	heterozygous	1	0.498	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	CCT	12	p.Thr725Pro	c.2173A>C	1.0	0.0	38.0	C	GMAF=0.4703:AMAF=0.3926:EMAF=0.4001	0.03		Benign	3812428	rs732609		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	2.92														M	
chr2:1516904	SNV	T	1	C/C	PASS	0.0	3393.67		341	T=0,C=341	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.336	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	GCG	15	p.Val847Ala	c.2540T>C	1.0	0.0	64.0	C	GMAF=0.3867:AMAF=0.2288:EMAF=0.4677	0		Benign	148793	rs1126799		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.63														M	
chr2:1542589	SNV	G	1	G/T	PASS	3.7601052366849176e-91	904.248		400	G=200,T=200	G=0.5,T=0.5	50.00	50.0	heterozygous	1	0.095	3		TPO	NM_000547.5	TPO:utr_3:NM_000547.5	unknown		17	p.?	c.*115G>T				T	GMAF=0.0727:AMAF=0.0195:EMAF=0.0959	0.01		Benign	5653833	rs28915689:rs1353412577:rs1558451361		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.06														M	
chr2:149571002	SNV	C	1	C/T	PASS	4.809500785491018e-32	313.179		148	C=77,T=71	C=0.5203,T=0.4797	47.97	52.03	heterozygous	1	0.378	1		MMADHC	NM_015702.3	MMADHC:intronic:NM_015702.3	unknown			p.?	c.696+83G>A				T						rs4500908		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-0.28														M	
chr2:149575863	SNV	C	1	C/G	PASS	2.306747188720142e-109	1086.37		399	C=181,G=218	C=0.4536,G=0.5464	54.64	45.36	heterozygous	1	0.378	2		MMADHC	NM_015702.3	MMADHC:intronic:NM_015702.3	unknown			p.?	c.479-22G>C				G	GMAF=0.3774:AMAF=0.3115:EMAF=0.2178			Likely benign		rs12232959		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-2.14														M	
chr2:149575955	SNV	G	1	G/T	PASS	2.1379620895022242e-107	1066.7		400	G=183,T=217	G=0.4575,T=0.5425	54.25	45.75	heterozygous	1	0.369	1		MMADHC	NM_015702.3	MMADHC:intronic:NM_015702.3	unknown			p.?	c.479-114C>A				T						rs10932467		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-1.8														M	
chr2:149576462	SNV	C	1	T/T	PASS	0.0	3987.71		399	C=0,T=399	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.24	1		MMADHC	NM_015702.3	MMADHC:exonic:NM_015702.3	synonymous	CAA	5	p.Gln151=	c.453G>A				T	GMAF=0.2261:AMAF=0.4839:EMAF=0.094	0.38		Benign	7128893	rs11545261		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-0.09														M	
chr2:149579375	INDEL	C	2	C/CAA	PASS	1.7827892225796729e-37	367.489		395	C=202,CAA=193	C=0.5114,CAA=0.4886	48.86	51.14	heterozygous	1	0.352	2		MMADHC	NM_015702.3	MMADHC:intronic:NM_015702.3	unknown			p.?	c.372+55_372+56insTT				CAA						rs36108609:rs1573878596		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-1.05														M	
chr2:149587175	SNV	C	1	G/G	PASS	0.0	3735.96		375	C=0,G=375	C=0.0,G=1.0	100.00	0.0	homozygous	1	0.311	1		MMADHC|MMADHC-DT	NM_015702.3|NR_110240.1	MMADHC:intronic:NM_015702.3|MMADHC-DT:upstream:NR_110240.1	unknown|	|	|	p.?|	c.-52-26G>C|	|	|	|	G|	GMAF=0.2632:AMAF=0.3497:EMAF=0.0949					rs4667420		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-0.12														M	
chr3:49421681	SNV	A	1	C/C	PASS	9.977e-319	3180.01		336	A=5,C=331	A=0.0149,C=0.9851	98.51	1.4899999999999949	homozygous	1	0.417	3		AMT|NICN1	NR_028435.2|NM_032316.3	AMT:intronic_nc:NR_028435.2|NICN1:downstream:NM_032316.3	|unknown	|	|	|p.?	|c.*3152T>G	|	|	|	|C						rs4855873		(dui:D009750;dis:Nutritional and Metabolic Diseases;g:AMT)(dui:D008659;dis:Metabolic Diseases;g:AMT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:AMT)(dui:D009422;dis:Nervous System Diseases;g:AMT)(dui:D030342;dis:Genetic Diseases, Inborn;g:AMT)(dui:D008661;dis:Metabolism, Inborn Errors;g:AMT)(dui:D002493;dis:Central Nervous System Diseases;g:AMT)(dui:D001927;dis:Brain Diseases;g:AMT)(dui:D001928;dis:Brain Diseases, Metabolic;g:AMT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:AMT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:AMT)(dui:D020158;dis:Hyperglycinemia, Nonketotic;g:AMT)	Tetrahydrofolic acid:NADH:5-methyltetrahydrofolic acid:Glycine	GO:0005515:GO:0005654:GO:0005874	238310:611516		1.08														M	
chr3:183017394	SNV	C	1	A/A	PASS	0.0	3589.64		359	C=0,A=359	C=0.0,A=1.0	100.00	0.0	homozygous	1	0.047	1		MCCC1	NM_020166.5	MCCC1:intronic:NM_020166.5	unknown			p.?	c.1978-57G>T				A	GMAF=0.0675:AMAF=0.065:EMAF=0.0685					rs6786878		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	-0.36														M	
chr3:183037421	SNV	T	1	T/G	PASS	1.262118114570758e-82	818.989		399	T=208,G=191	T=0.5213,G=0.4787	47.87	52.13	heterozygous	1	0.465	1		MCCC1	NM_020166.5	MCCC1:exonic:NM_020166.5	missense	CCC	13	p.His464Pro	c.1391A>C	0.01	0.0	77.0	G	GMAF=0.4152:AMAF=0.2876:EMAF=0.2629	0.92		Benign	4002526	rs2270968		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	1.12														M	
chr3:183072461	SNV	G	1	A/A	PASS	0.0	3966.32		400	G=1,A=399	G=0.0025,A=0.9975	99.75	0.25	homozygous	1	0.084	1		MCCC1	NM_020166.5	MCCC1:exonic:NM_020166.5	synonymous	CTT	5	p.Leu132=	c.396C>T				A	GMAF=0.1147:AMAF=0.2034:EMAF=0.0692			Benign		rs7622479		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	0.89														M	
chr4:145650988	SNV	G	1	G/A	PASS	1.8650908866069556e-75	747.293		400	G=217,A=183	G=0.5425,A=0.4575	45.75	54.25	heterozygous	1	0.277	2		MMAA	NM_001375644.1	MMAA:intronic:NM_001375644.1	unknown			p.?	c.734-74G>A				A						rs11721510		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMAA)(dui:NBS2;dis:Core Conditions;g:MMAA)(dui:NBS9;dis:Organic Acid Condition;g:MMAA)(dui:NBS43;dis:Methylmalonic acidemia;g:MMAA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMAA)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMAA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMAA)(dui:D008659;dis:Metabolic Diseases;g:MMAA)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMAA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMAA)	Hydroxocobalamin:Cyanocobalamin		607481		-0.22														M	
chr4:145655266	SNV	G	1	G/C	PASS	1.6634126503701834e-85	847.79		400	G=206,C=194	G=0.515,C=0.485	48.50	51.5	heterozygous	1	0.081	1		MMAA	NM_001375644.1	MMAA:exonic:NM_001375644.1	missense	CAC	7	p.Gln363His	c.1089G>C	0.05	0.001	24.0	C	GMAF=0.051:AMAF=0.0458:EMAF=0.0536	0.93:0.95		Benign	7081209:7302484	rs2270655		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMAA)(dui:NBS2;dis:Core Conditions;g:MMAA)(dui:NBS9;dis:Organic Acid Condition;g:MMAA)(dui:NBS43;dis:Methylmalonic acidemia;g:MMAA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMAA)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMAA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMAA)(dui:D008659;dis:Metabolic Diseases;g:MMAA)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMAA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMAA)	Hydroxocobalamin:Cyanocobalamin		607481		3.25														M	
chr4:158680524	SNV	C	1	T/T	PASS	0.0	4003.26		400	C=0,T=400	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.327	1		ETFDH	NM_004453.4	ETFDH:exonic:NM_004453.4	missense	ATA	2	p.Thr31Ile	c.92C>T	0.1	0.0	89.0	T	GMAF=0.3434:AMAF=0.2596:EMAF=0.14	0.84		Benign	4158888	rs11559290		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFDH)(dui:NBS3;dis:Secondary Conditions;g:ETFDH)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFDH)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFDH)(dui:D008659;dis:Metabolic Diseases;g:ETFDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFDH)(dui:D028361;dis:Mitochondrial Diseases;g:ETFDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFDH)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFDH)(dui:D009748;dis:Nutrition Disorders;g:ETFDH)(dui:D044343;dis:Overnutrition;g:ETFDH)(dui:D009765;dis:Obesity;g:ETFDH)	Metformin:2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	GO:0009055:GO:0022904:GO:0043783:GO:0004174:GO:0022900:GO:0048039:GO:0006979:GO:0031305:GO:0033539:GO:0005515:GO:0031966:GO:0048038:GO:0005759:GO:0016491:GO:0046872:GO:0050660:GO:0051539	231675	PF01946:PF13450:PF05187:PF00890	1.1														M	
chr5:71626789	SNV	G	1	G/A	PASS	5.3223079582835474e-58	572.739		291	G=155,A=136	G=0.5326,A=0.4674	46.74	53.26	heterozygous	1	0.186	1		MCCC2	NM_022132.5	MCCC2:intronic:NM_022132.5	unknown			p.?	c.738+36G>A				A	GMAF=0.2032:AMAF=0.2797:EMAF=0.164			Benign		rs12516456		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	-0.73														M	
chr5:71635139	SNV	A	1	A/G	PASS	3.3535130445055596e-90	894.745		400	A=201,G=199	A=0.5025,G=0.4975	49.75	50.25	heterozygous	1	0.33	1		MCCC2	NM_022132.5	MCCC2:intronic:NM_022132.5	unknown			p.?	c.904-12A>G				G	GMAF=0.2889:AMAF=0.1416:EMAF=0.3643			Benign		rs277984		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	-1.82														M	
chr5:71649248	SNV	A	1	A/G	PASS	3.288516308759799e-95	944.83		399	A=195,G=204	A=0.4887,G=0.5113	51.13	48.87	heterozygous	1	0.149	1		MCCC2	NM_022132.5	MCCC2:exonic:NM_022132.5	synonymous	GCG	14	p.Ala456=	c.1368A>G				G	GMAF=0.1868:AMAF=0.2935:EMAF=0.1321	0.07		Benign	4407210	rs10064079		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	-1.2														M	
chr5:71652827	SNV	G	1	G/A	PASS	3.2553673247163035e-78	774.874		400	G=214,A=186	G=0.535,A=0.465	46.50	53.5	heterozygous	1	0.186	1		MCCC2	NM_022132.5	MCCC2:intronic:NM_022132.5	unknown			p.?	c.1574+73G>A				A						rs2242372		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	0.28														M	
chr6:32038450	INDEL	CTGC	3	C/C	PASS	2.2029264630534023e-239	2386.57		246	CTGC=0,C=246	CTGC=0.0,C=1.0	100.00	0.0	homozygous	1		1		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	nonframeshiftDeletion		1	p.Leu10del	c.29_31delTGC				C	GMAF=0.1888:AMAF=0.0762:EMAF=0.2467					rs1554304337:rs28381641:rs1401750531:rs1424110213:rs1170743134:rs764653902		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.35,0.73,1.19,-1.31														M	
chr6:32038540	SNV	C	1	T/T	PASS	1.0092528860766629e-209	2089.96		214	C=1,T=213	C=0.0047,T=0.9953	99.53	0.46999999999999886	homozygous	1		2		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	synonymous	TTG	1	p.Leu40=	c.118C>T				T		0.61		Benign	4160891	rs6468		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.09														M	
chr6:32038560	SNV	C	1	C/A	PASS	1.72147214573708e-45	447.641		176	C=83,A=93	C=0.4716,A=0.5284	52.84	47.16	heterozygous	1		4		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	synonymous	CCA	1	p.Pro46=	c.138C>A				A		0.05		Benign	4160892	rs6464		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.44														M	
chr6:32038820	SNV	C	1	T/T	PASS	1.9467043530014172e-84	837.107		85	C=0,T=85	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.288	2		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.292+9C>T				T				Benign		rs6462		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-1.82														M	
chr6:32038844	SNV	A	1	C/C	PASS	1.9386526359521815e-85	847.125		88	A=1,C=87	A=0.0114,C=0.9886	98.86	1.1400000000000006	homozygous	1	0.218	7		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.292+33A>C				C	GMAF=0.2224:AMAF=0.0745:EMAF=0.2975					rs755425808:rs6463		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	1.04														M	
chr6:32038878	SNV	C	1	T/T	PASS	5.025739801095915e-91	902.988		90	C=0,T=90	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.218	1		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.292+67C>T				T						rs6449		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-2.74														M	
chr6:32039109	SNV	G	1	G/A	PASS	3.246459579514043e-07	64.8859		35	G=20,A=15	G=0.5714,A=0.4286	42.86	57.14	heterozygous	1	0.215	2		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	missense	AAG	3	p.Arg103Lys	c.308G>A	0.48	0.0	26.0	A	GMAF=0.2315:AMAF=0.0693:EMAF=0.3145	0		Benign	1319109	rs6474		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-0.6														M	
chr6:32040216	SNV	G	1	G/C	PASS	9.609482495282797e-51	500.173		374	G=227,C=147	G=0.607,C=0.393	39.30	60.7	heterozygous	1	0.024	4		CYP21A2|TNXB	NM_000500.9|NM_001365276.2	CYP21A2:intronic:NM_000500.9|TNXB:downstream:NM_001365276.2	unknown|unknown	|	|	p.?|p.?	c.939+11G>C|c.*1133C>G	|	|	|	C|C				Benign		rs6442		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:TNXB)(dui:D003240;dis:Connective Tissue Diseases;g:TNXB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TNXB)(dui:D030342;dis:Genetic Diseases, Inborn;g:TNXB)(dui:D012871;dis:Skin Diseases;g:TNXB)(dui:D002318;dis:Cardiovascular Diseases;g:TNXB)(dui:D014652;dis:Vascular Diseases;g:TNXB)(dui:D012873;dis:Skin Diseases, Genetic;g:TNXB)(dui:D000013;dis:Congenital Abnormalities;g:TNXB)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:TNXB)(dui:D006402;dis:Hematologic Diseases;g:TNXB)(dui:D003095;dis:Collagen Diseases;g:TNXB)(dui:D006474;dis:Hemorrhagic Disorders;g:TNXB)(dui:D012868;dis:Skin Abnormalities;g:TNXB)(dui:D020141;dis:Hemostatic Disorders;g:TNXB)(dui:D004535;dis:Ehlers-Danlos Syndrome;g:TNXB)(dui:D007154;dis:Immune System Diseases;g:TNXB)(dui:D001327;dis:Autoimmune Diseases;g:TNXB)(dui:D008180;dis:Lupus Erythematosus, Systemic;g:TNXB)(dui:D005128;dis:Eye Diseases;g:TNXB)(dui:D012164;dis:Retinal Diseases;g:TNXB)(dui:D012162;dis:Retinal Degeneration;g:TNXB)(dui:D008268;dis:Macular Degeneration;g:TNXB)(dui:D006967;dis:Hypersensitivity;g:TNXB)(dui:D003872;dis:Dermatitis;g:TNXB)(dui:D006969;dis:Hypersensitivity, Immediate;g:TNXB)(dui:D006973;dis:Hypertension;g:TNXB)(dui:D017443;dis:Skin Diseases, Eczematous;g:TNXB)(dui:D003876;dis:Dermatitis, Atopic;g:TNXB)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	600985:613815	PF00067	1.61														M	
chr6:39916058	SNV	A	1	A/T	PASS	1.1585105685247379e-70	699.361		299	A=147,T=152	A=0.4916,T=0.5084	50.84	49.16	heterozygous	1	0.063	1		MOCS1	NM_001358530.2	MOCS1:intronic:NM_001358530.2	unknown			p.?	c.583+10T>A				T	GMAF=0.0624:AMAF=0.0645:EMAF=0.0614			Benign		rs34757428		(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MOCS1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MOCS1)(dui:D008659;dis:Metabolic Diseases;g:MOCS1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MOCS1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MOCS1)(dui:D008664;dis:Metal Metabolism, Inborn Errors;g:MOCS1)			603707	PF01967:PF04055:PF06463:PF13353	-0.19														M	
chr6:49435569	SNV	T	1	C/C	PASS	0.0	3971.44		400	T=0,C=400	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.451	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	missense	GTA	12	p.Ile671Val	c.2011A>G	1.0	0.0	29.0	C	GMAF=0.393:AMAF=0.4122:EMAF=0.3833	0.25		Benign	4004063	rs8589		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	3.9														M	
chr6:49441774	SNV	G	1	C/C	PASS	0.0	4002.92		400	G=0,C=400	G=0.0,C=1.0	100.00	0.0	homozygous	1	0.329	1		MMUT	NM_000255.4	MMUT:intronic:NM_000255.4	unknown			p.?	c.1808+66C>G				C						rs9473555		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	0.46														M	
chr6:49444720	SNV	C	1	T/T	PASS	0.0	4003.33		400	C=0,T=400	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.266	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	missense	CAT	9	p.Arg532His	c.1595G>A	0.0	0.225	29.0	T	GMAF=0.3135:AMAF=0.2108:EMAF=0.366	0.03		Benign	5001998	rs1141321		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	-0.01														M	
chr6:49457808	SNV	C	1	T/T	PASS	0.0	3924.89		399	C=2,T=397	C=0.005,T=0.995	99.50	0.5	homozygous	1	0.449	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	synonymous	AAA	3	p.Lys212=	c.636G>A				T	GMAF=0.3984:AMAF=0.4274:EMAF=0.3836	0.39		Benign	6350580	rs2229384		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	0.67														M	
chr6:80107031	SNV	T	1	T/C	PASS	1.5969819223382974e-54	537.967		266	T=140,C=126	T=0.5263,C=0.4737	47.37	52.63	heterozygous	1	0.388	1		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.196+142T>C				C						rs35447745		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	-1.0														M	
chr6:80127522	SNV	A	1	A/G	PASS	6.318296466918913e-37	361.994		265	A=160,G=105	A=0.6038,G=0.3962	39.62	60.38	heterozygous	1	0.388	3		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.197-25A>G				G	GMAF=0.323:AMAF=0.1148:EMAF=0.4297			Benign		rs9448893		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	0.45														M	
chr6:80167654	SNV	C	1	C/T	PASS	1.897579587720841e-86	857.218		400	C=205,T=195	C=0.5125,T=0.4875	48.75	51.25	heterozygous	1	0.13	2		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.344-24C>T				T	GMAF=0.0657:AMAF=0.0985:EMAF=0.0488			Benign/Likely benign		rs73479953		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	-1.74														M	
chr6:80168795	SNV	G	1	A/A	PASS	4.860041749236718e-07	63.1336		7	G=0,A=7	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.0	3		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.478-80G>A				A						rs72908865		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	0.72														M	
chr6:80203260	SNV	C	1	C/T	PASS	1.7906058540352948e-121	1207.47		398	C=169,T=229	C=0.4246,T=0.5754	57.54	42.46	heterozygous	1	0.13	2		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.951+48C>T				T	GMAF=0.0658:AMAF=0.0987:EMAF=0.049			Benign/Likely benign		rs3749896		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	-0.16														M	
chr6:80272984	SNV	G	1	G/A	PASS	4.141903726220978e-92	913.828		400	G=199,A=201	G=0.4975,A=0.5025	50.25	49.75	heterozygous	1	0.403	1		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.952-151G>A				A						rs9341811		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	-0.85														M	
chr7:117536538	INDEL	TGATT	4	T/T	PASS	2.9512092266661848e-269	2685.3		274	TGATT=1,T=273	TGATT=0.0036,T=0.9964	99.63	0.37000000000000455	homozygous	1		1		CFTR	NM_000492.4	CFTR:intronic:NM_000492.4	unknown			p.?	c.744-9_744-6delGATT				T						rs1584787644:rs397508793:rs387906367:rs1584787639:rs1554380751:rs878854022		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.15,0.0,0.0,-0.48,2.25														M	
chr7:117548629	INDEL	T	4	T/TGTGT	PASS	1.4699413265138498e-32	318.327		118	T=46,TGTGT=72	T=0.3898,TGTGT=0.6102	61.02	38.98	heterozygous	1	0.071:0.003	0		CFTR|CFTR-AS1	NM_000492.4|NR_149084.1	CFTR:intronic:NM_000492.4|CFTR-AS1:intronic_nc:NR_149084.1	unknown|	|	|	p.?|	c.1210-12_1210-11insGTGT|	|	|	|	TGTGT|			5T			rs4148705:rs1584793368:rs1805177:rs765376630:rs1399483116		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.56														M	
chr7:117559403	SNV	A	1	G/G	PASS	0.0	3982.28		399	A=0,G=399	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.337	1		CFTR|CFTR-AS1	NM_000492.4|NR_149084.1	CFTR:intronic:NM_000492.4|CFTR-AS1:intronic_nc:NR_149084.1	unknown|	|	|	p.?|	c.1393-61A>G|	|	|	|	G|				Benign		rs34855237		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.3														M	
chr7:117559479	SNV	G	1	A/A	PASS	0.0	3990.13		400	G=0,A=400	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.418	2		CFTR|CFTR-AS1	NM_000492.4|NR_149084.1	CFTR:exonic:NM_000492.4|CFTR-AS1:intronic_nc:NR_149084.1	missense|	ATG|	11|	p.Val470Met|	c.1408G>A|	1.0|	0.0|	21.0|	A|	GMAF=0.4024:AMAF=0.1496:EMAF=0.4681	0.39	M470V	Benign/Likely benign	3762337	rs397508204:rs213950		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		2.57														M	
chr7:117595001	SNV	T	1	G/G	PASS	0.0	3992.62		399	T=0,G=399	T=0.0,G=1.0	100.00	0.0	homozygous	1	0.479	1		CFTR	NM_000492.4	CFTR:exonic:NM_000492.4	synonymous	ACG	15	p.Thr854=	c.2562T>G				G	GMAF=0.4028:AMAF=0.3813:EMAF=0.2922	0.13		Benign/Likely benign	4161733	rs1584813846:rs1554389814:rs397508396:rs1042077		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.28														M	
chr8:142875392	SNV	A	1	C/C	PASS	0.0	3971.46		398	A=0,C=398	A=0.0,C=1.0	100.00	0.0	homozygous	1	0.259	2		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.1122-80T>G				C						rs6395		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-2.29														M	
chr8:142875509	SNV	T	1	C/C	PASS	0.0	3940.66		400	T=1,C=399	T=0.0025,C=0.9975	99.75	0.25	homozygous	1	0.24	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.1122-197A>G				C						rs6392		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-2.07														M	
chr8:142876440	SNV	G	1	A/A	PASS	0.0	4003.33		400	G=0,A=400	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.315	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.800-45C>T				A	GMAF=0.4197:AMAF=0.3926:EMAF=0.4336					rs7822986		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-1.98														M	
chr8:142876563	SNV	A	1	C/C	PASS	1.023292992280733e-130	1299.9		159	A=12,C=147	A=0.0755,C=0.9245	92.45	7.549999999999997	homozygous	1	0.382	2		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.799+119T>G				C						rs10956991		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-3.19														M	
chr8:142877011	SNV	C	1	T/T	PASS	0.0	4003.32		400	C=0,T=400	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.436	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.595+12G>A				T	GMAF=0.4845:AMAF=0.3736:EMAF=0.4587			Benign		rs6387		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-3.01														M	
chr8:142879181	SNV	G	1	A/A	PASS	0.0	3625.76		375	G=3,A=372	G=0.008,A=0.992	99.20	0.7999999999999972	homozygous	1	0.303	1		CYP11B1	NM_000497.4	CYP11B1:exonic:NM_000497.4	synonymous	GAT	2	p.Asp82=	c.246C>T				A	GMAF=0.3283:AMAF=0.1117:EMAF=0.4393	0.01		Benign	4162721	rs5283		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-0.46														M	
chr8:142879589	SNV	T	1	C/C	PASS	2.88403150312647e-262	2615.4		263	T=0,C=263	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.416	1		CYP11B1	NM_000497.4	CYP11B1:exonic:NM_000497.4	synonymous	CTG	1	p.Leu75=	c.225A>G				C	GMAF=0.4923:AMAF=0.4424:EMAF=0.4588	0.05		Benign	6338105	rs6410		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-0.64														M	
chr10:102831636	SNV	G	1	T/T	PASS	0.0	3983.68		399	G=0,T=399	G=0.0,T=1.0	100.00	0.0	homozygous	1	0.18	1		CYP17A1	NM_000102.4	CYP17A1:intronic:NM_000102.4	unknown			p.?	c.1140-25C>A				T	GMAF=0.0847:AMAF=0.0645:EMAF=0.0951					rs17115100		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-0.12														M	
chr10:102832918	SNV	G	1	C/C	PASS	0.0	3910.77		400	G=2,C=398	G=0.005,C=0.995	99.50	0.5	homozygous	1	0.35	1		CYP17A1	NM_000102.4	CYP17A1:intronic:NM_000102.4	unknown			p.?	c.969+75C>G				C						rs3740397		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	0.26														M	
chr10:102834750	SNV	A	1	G/G	PASS	5.07e-321	3202.95		322	A=0,G=322	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.219	1		CYP17A1	NM_000102.4	CYP17A1:intronic:NM_000102.4	unknown			p.?	c.666+35T>C				G	GMAF=0.1249:AMAF=0.18:EMAF=0.0967					rs1004467		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-0.23														M	
chr10:102837167	SNV	C	1	A/A	PASS	1.002305238077911e-186	1859.99		189	C=1,A=188	C=0.0053,A=0.9947	99.47	0.5300000000000011	homozygous	1	0.41	2		CYP17A1	NM_000102.4	CYP17A1:exonic:NM_000102.4	synonymous	TCT	1	p.Ser65=	c.195G>T				A	GMAF=0.3833:AMAF=0.3616:EMAF=0.3944	0.17		Benign	3751499	rs6163		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-0.04														M	
chr10:102837224	SNV	G	1	A/A	PASS	0.0	3966.52		400	G=1,A=399	G=0.0025,A=0.9975	99.75	0.25	homozygous	1	0.443	1		CYP17A1	NM_000102.4	CYP17A1:exonic:NM_000102.4	synonymous	CAT	1	p.His46=	c.138C>T				A	GMAF=0.3949:AMAF=0.3645:EMAF=0.4105	0.02		Benign	3751500	rs6162		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-0.11														M	
chr10:102837395	SNV	A	1	G/G	PASS	0.0	4003.15		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.41	1		CYP17A1	NM_000102.4	CYP17A1:utr_5:NM_000102.4	unknown		1	p.?	c.-34T>C				G	GMAF=0.3823:AMAF=0.3608:EMAF=0.3934			Benign		rs743572		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-0.52														M	
chr10:123040644	SNV	C	1	C/G	PASS	5.679367867720042e-96	952.457		400	C=195,G=205	C=0.4875,G=0.5125	51.25	48.75	heterozygous	1		2		ACADSB	NM_001609.4	ACADSB:exonic:NM_001609.4	missense	AGC	4	p.Thr161Ser	c.482C>G	0.01	0.058	58.0	G								(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADSB)(dui:NBS3;dis:Secondary Conditions;g:ACADSB)(dui:NBS18;dis:2-Methylbutyrylglycinuria;g:ACADSB)(dui:NBS4;dis:Organic Acid Condition;g:ACADSB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADSB)(dui:D008659;dis:Metabolic Diseases;g:ACADSB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADSB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADSB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADSB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACADSB)(dui:D001523;dis:Mental Disorders;g:ACADSB)(dui:D065886;dis:Neurodevelopmental Disorders;g:ACADSB)(dui:D002659;dis:Child Development Disorders, Pervasive;g:ACADSB)(dui:D001321;dis:Autistic Disorder;g:ACADSB)	Valproic acid:Isoleucine	GO:0003853:GO:0042802:GO:0009083:GO:0005759:GO:0050660:GO:0016937:GO:0005739:GO:0102035:GO:0006550:GO:0055114:GO:0006631	600301		2.91														M	
chr10:123041039	INDEL	AT	1	A/A	PASS	1.0471285480509242e-170	1699.8		305	AT=0,A=305	AT=0.0,A=1.0	100.00	0.0	homozygous	1	0.035	6		ACADSB	NM_001609.4	ACADSB:intronic:NM_001609.4	unknown			p.?	c.511-169delT				A						rs1589741386:rs11300559		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADSB)(dui:NBS3;dis:Secondary Conditions;g:ACADSB)(dui:NBS18;dis:2-Methylbutyrylglycinuria;g:ACADSB)(dui:NBS4;dis:Organic Acid Condition;g:ACADSB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADSB)(dui:D008659;dis:Metabolic Diseases;g:ACADSB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADSB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADSB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADSB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACADSB)(dui:D001523;dis:Mental Disorders;g:ACADSB)(dui:D065886;dis:Neurodevelopmental Disorders;g:ACADSB)(dui:D002659;dis:Child Development Disorders, Pervasive;g:ACADSB)(dui:D001321;dis:Autistic Disorder;g:ACADSB)	Valproic acid:Isoleucine	GO:0003853:GO:0042802:GO:0009083:GO:0005759:GO:0050660:GO:0016937:GO:0005739:GO:0102035:GO:0006550:GO:0055114:GO:0006631	600301		-0.13,0.0														M	
chr10:123041337	SNV	C	1	T/T	PASS	0.0	4003.26		400	C=0,T=400	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.228	1		ACADSB	NM_001609.4	ACADSB:exonic:NM_001609.4	synonymous	CAT	5	p.His213=	c.639C>T				T	GMAF=0.2281:AMAF=0.2156:EMAF=0.2345	0.02		Benign	3997809	rs1140591		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADSB)(dui:NBS3;dis:Secondary Conditions;g:ACADSB)(dui:NBS18;dis:2-Methylbutyrylglycinuria;g:ACADSB)(dui:NBS4;dis:Organic Acid Condition;g:ACADSB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADSB)(dui:D008659;dis:Metabolic Diseases;g:ACADSB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADSB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADSB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADSB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACADSB)(dui:D001523;dis:Mental Disorders;g:ACADSB)(dui:D065886;dis:Neurodevelopmental Disorders;g:ACADSB)(dui:D002659;dis:Child Development Disorders, Pervasive;g:ACADSB)(dui:D001321;dis:Autistic Disorder;g:ACADSB)	Valproic acid:Isoleucine	GO:0003853:GO:0042802:GO:0009083:GO:0005759:GO:0050660:GO:0016937:GO:0005739:GO:0102035:GO:0006550:GO:0055114:GO:0006631	600301		-1.56														M	
chr11:5226496	SNV	G	1	G/A	PASS	4.9181299526830836e-98	973.082		388	G=184,A=204	G=0.4742,A=0.5258	52.58	47.42	heterozygous	1	0.099	1		HBB	NM_000518.5	HBB:intronic:NM_000518.5	unknown			p.?	c.315+81C>T				A				Benign		rs7946748		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	-0.45														M	
chr11:5226503	SNV	A	1	A/C	PASS	3.647539469256058e-78	774.38		388	A=205,C=183	A=0.5284,C=0.4716	47.16	52.84	heterozygous	1	0.369	1		HBB	NM_000518.5	HBB:intronic:NM_000518.5	unknown			p.?	c.315+74T>G				C				Benign		rs7480526		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	0.17														M	
chr11:5226561	SNV	C	1	C/G	PASS	4.00774425280436e-78	773.971		400	C=214,G=186	C=0.535,G=0.465	46.50	53.5	heterozygous	1	0.28	1		HBB	NM_000518.5	HBB:intronic:NM_000518.5	unknown			p.?	c.315+16G>C				G	GMAF=0.1491:AMAF=0.1297:EMAF=0.159			Benign/Likely benign		rs10768683		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	-3.19														M	
chr11:5227013	SNV	A	1	A/G	PASS	3.0136998743411634e-88	875.209		400	A=203,G=197	A=0.5075,G=0.4925	49.25	50.75	heterozygous	1	0.286	1		HBB	NM_000518.5	HBB:exonic:NM_000518.5	synonymous	CAC	1	p.His3=	c.9T>C				G	GMAF=0.1513:AMAF=0.1361:EMAF=0.1591	0.1		Benign	6484194	rs713040:rs63750898:rs63750407		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	-0.89														M	
chr11:68780792	SNV	C	1	A/A	PASS	0.0	3963.36		396	C=0,A=396	C=0.0,A=1.0	100.00	0.0	homozygous	1	0.107	1		CPT1A	NM_001876.4	CPT1A:intronic:NM_001876.4	unknown			p.?	c.1353-47G>T				A	GMAF=0.0881:AMAF=0.1534:EMAF=0.0546					rs750602950:rs3019576		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	-0.99														M	
chr11:68781872	SNV	A	1	G/G	PASS	0.0	3811.78		400	A=5,G=395	A=0.0125,G=0.9875	98.75	1.25	homozygous	1	0.107	3		CPT1A	NM_001876.4	CPT1A:exonic:NM_001876.4	synonymous	TTC	11	p.Phe417=	c.1251T>C				G	GMAF=0.088:AMAF=0.153:EMAF=0.0547			Benign		rs755361411:rs2228502		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	0.3														M	
chr11:68799181	MNV	AAA	3	GCT/GCT	PASS	4.854896771016029e-07	63.1382		7	AAA=0,GCT=7	AAA=0.0,GCT=1.0	100.00	0.0	0	1	0.436:0.281:0.157	5		CPT1A	NM_001876.4	CPT1A:intronic:NM_001876.4	unknown			p.?	c.693+35_693+37delinsAGC				GCT						rs61887062:rs373853770:rs61887064:rs200844352:rs67266031:rs1302471537:rs61887063:rs1555230749:rs371123694:rs753779449:rs776600347		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	0.35,0.91,0.14														M	
chr11:68807709	SNV	G	1	G/A	PASS	6.194410750767837e-89	882.08		390	G=195,A=195	G=0.5,A=0.5	50.00	50.0	heterozygous	1	0.017	1		CPT1A	NM_001876.4	CPT1A:intronic:NM_001876.4	unknown			p.?	c.282-71C>T				A						rs41302431		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	-1.97														M	
chr11:108141783	INDEL	A	4	AAAGT/AAAGT	PASS	0.0	3630.92		381	A=4,AAAGT=377	A=0.0105,AAAGT=0.9895	98.95	1.0499999999999972	homozygous	1	0.007:0.003	5		ACAT1	NM_000019.4	ACAT1:intronic:NM_000019.4	unknown			p.?	c.826+83_826+84insAAGT				AAAGT				Benign		rs10682490:rs34420529		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	1.38														M	
chr11:108142634	SNV	C	1	T/T	PASS	0.0	3957.87		399	C=1,T=398	C=0.0025,T=0.9975	99.75	0.25	homozygous	1	0.262	1		ACAT1	NM_000019.4	ACAT1:intronic:NM_000019.4	unknown			p.?	c.940+84C>T				T						rs12794010		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	0.95														M	
chr12:56004670	SNV	G	1	C/C	PASS	0.0	3967.01		400	G=1,C=399	G=0.0025,C=0.9975	99.75	0.25	homozygous	1	0.237	2		SUOX	NM_001032387.2	SUOX:exonic:NM_001032387.2	synonymous	TCC	4	p.Ser427=	c.1281G>C				C	GMAF=0.2642:AMAF=0.3768:EMAF=0.0802			Benign		rs1565799723:rs773115		(dui:D009750;dis:Nutritional and Metabolic Diseases;g:SUOX)(dui:D008659;dis:Metabolic Diseases;g:SUOX)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:SUOX)(dui:D030342;dis:Genetic Diseases, Inborn;g:SUOX)(dui:D008661;dis:Metabolism, Inborn Errors;g:SUOX)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:SUOX)(dui:D007154;dis:Immune System Diseases;g:SUOX)(dui:D004700;dis:Endocrine System Diseases;g:SUOX)(dui:D001327;dis:Autoimmune Diseases;g:SUOX)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:SUOX)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:SUOX)(dui:D009140;dis:Musculoskeletal Diseases;g:SUOX)(dui:D009369;dis:Neoplasms;g:SUOX)(dui:D003240;dis:Connective Tissue Diseases;g:SUOX)(dui:D003560;dis:Cysts;g:SUOX)(dui:D006058;dis:Gonadal Disorders;g:SUOX)(dui:D007592;dis:Joint Diseases;g:SUOX)(dui:D012216;dis:Rheumatic Diseases;g:SUOX)(dui:D052776;dis:Female Urogenital Diseases;g:SUOX)(dui:D001168;dis:Arthritis;g:SUOX)(dui:D001172;dis:Arthritis, Rheumatoid;g:SUOX)(dui:D005831;dis:Genital Diseases, Female;g:SUOX)(dui:D010048;dis:Ovarian Cysts;g:SUOX)(dui:D010049;dis:Ovarian Diseases;g:SUOX)(dui:D000291;dis:Adnexal Diseases;g:SUOX)(dui:D011085;dis:Polycystic Ovary Syndrome;g:SUOX)	{[2-Amino-4-oxo-6,7-di(sulfanyl-S)-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)sulfanylmolybdenum	GO:0005758:GO:0005515:GO:0006790:GO:0070221:GO:0005759:GO:0005739:GO:0008482:GO:0030151:GO:0020037:GO:0043546	606887	PF00173:PF00174:PF03404	-1.35														M	
chr12:102843690	SNV	G	1	C/C	PASS	0.0	4003.3		400	G=0,C=400	G=0.0,C=1.0	100.00	0.0	homozygous	1	0.16	1		PAH	NM_001354304.2	PAH:exonic:NM_001354304.2	synonymous	CTG	12	p.Leu385=	c.1155C>G				C	GMAF=0.1728:AMAF=0.1959:EMAF=0.161			Benign		rs772897		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-0.1														M	
chr12:102846852	SNV	C	1	A/A	PASS	0.0	3797.6		391	C=3,A=388	C=0.0077,A=0.9923	99.23	0.769999999999996	homozygous	1	0.27	2		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.969+43G>T				A	GMAF=0.3666:AMAF=0.2685:EMAF=0.4169			Benign		rs1522306		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-1.11														M	
chr12:102855146	SNV	C	1	T/T	PASS	0.0	3972.02		400	C=0,T=400	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.454	1		PAH	NM_001354304.2	PAH:exonic:NM_001354304.2	synonymous	CAA	7	p.Gln232=	c.696G>A				T	GMAF=0.3465:AMAF=0.2317:EMAF=0.4052	0.02		Benign	7233325	rs1126758		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-2.59														M	
chr12:102855386	SNV	C	1	T/T	PASS	0.0	4002.99		400	C=0,T=400	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.235	1		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.510-54G>A				T				Benign		rs2251905		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-4.26														M	
chr12:102877415	SNV	G	1	A/A	PASS	3.169567463043733e-252	2514.99		269	G=6,A=263	G=0.0223,A=0.9777	97.77	2.230000000000004	homozygous	1	0.294	2		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.441+47C>T				A	GMAF=0.3828:AMAF=0.2851:EMAF=0.4329			Benign		rs1718301		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-1.57														M	
chr12:120737096	SNV	T	1	C/C	PASS	0.0	3964.31		399	T=0,C=399	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.409	1		ACADS	NM_000017.4	ACADS:exonic:NM_000017.4	synonymous	CGC	3	p.Arg107=	c.321T>C				C	GMAF=0.4932:AMAF=0.3756:EMAF=0.4466	0.28		Benign	3765623	rs1064795254:rs3914		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-0.18														M	
chr12:120738181	SNV	T	1	C/C	PASS	0.0	3993.13		399	T=0,C=399	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.406	1		ACADS	NM_000017.4	ACADS:intronic:NM_000017.4	unknown			p.?	c.625-99T>C				C						rs555404		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-2.88														M	
chr12:120738876	SNV	C	1	T/T	PASS	0.0	3996.22		400	C=0,T=400	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.327	1		ACADS	NM_000017.4	ACADS:exonic:NM_000017.4	synonymous	CGT	8	p.Arg330=	c.990C>T				T	GMAF=0.408:AMAF=0.1235:EMAF=0.4462	0.02		Benign	4146720	rs796051906:rs1555244280:rs3915		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-1.49														M	
chr13:20189202	SNV	C	1	C/T	PASS	4.103930524610086e-92	913.868		400	C=199,T=201	C=0.4975,T=0.5025	50.25	49.75	heterozygous	1	0.027	1		GJB2	NM_004004.6	GJB2:exonic:NM_004004.6	missense	CAC	2	p.Arg127His	c.380G>A			29.0	T	GMAF=0.0023:AMAF=9.0E-4:EMAF=0.003	0.45		Conflicting interpretations of pathogenicity	5052088	rs111033196		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:GJB2)(dui:NBS2;dis:Core Conditions;g:GJB2)(dui:NBS14;dis:Other Disorder;g:GJB2)(dui:NBS75;dis:Hearing Loss;g:GJB2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:GJB2)(dui:D000013;dis:Congenital Abnormalities;g:GJB2)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:GJB2)(dui:D012871;dis:Skin Diseases;g:GJB2)(dui:D009422;dis:Nervous System Diseases;g:GJB2)(dui:D009461;dis:Neurologic Manifestations;g:GJB2)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:GJB2)(dui:D004427;dis:Ear Diseases;g:GJB2)(dui:D012678;dis:Sensation Disorders;g:GJB2)(dui:D006311;dis:Hearing Disorders;g:GJB2)(dui:D034381;dis:Hearing Loss;g:GJB2)(dui:D007642;dis:Keratosis;g:GJB2)(dui:D006319;dis:Hearing Loss, Sensorineural;g:GJB2)(dui:D030342;dis:Genetic Diseases, Inborn;g:GJB2)(dui:D000015;dis:Abnormalities, Multiple;g:GJB2)(dui:D012873;dis:Skin Diseases, Genetic;g:GJB2)(dui:D009140;dis:Musculoskeletal Diseases;g:GJB2)(dui:D007645;dis:Keratoderma, Palmoplantar;g:GJB2)(dui:D006226;dis:Hand Deformities;g:GJB2)(dui:D009139;dis:Musculoskeletal Abnormalities;g:GJB2)(dui:D006228;dis:Hand Deformities, Congenital;g:GJB2)(dui:D017880;dis:Limb Deformities, Congenital;g:GJB2)(dui:D038062;dis:Upper Extremity Deformities, Congenital;g:GJB2)(dui:D012868;dis:Skin Abnormalities;g:GJB2)(dui:D007232;dis:Infant, Newborn, Diseases;g:GJB2)(dui:D007057;dis:Ichthyosis;g:GJB2)(dui:D005128;dis:Eye Diseases;g:GJB2)(dui:D003638;dis:Deafness;g:GJB2)(dui:D003316;dis:Corneal Diseases;g:GJB2)(dui:D007634;dis:Keratitis;g:GJB2)(dui:D009369;dis:Neoplasms;g:GJB2)(dui:D009371;dis:Neoplasms by Site;g:GJB2)(dui:D004066;dis:Digestive System Diseases;g:GJB2)(dui:D017444;dis:Skin Diseases, Papulosquamous;g:GJB2)(dui:D011565;dis:Psoriasis;g:GJB2)(dui:D004700;dis:Endocrine System Diseases;g:GJB2)(dui:D003240;dis:Connective Tissue Diseases;g:GJB2)(dui:D012874;dis:Skin Diseases, Infectious;g:GJB2)(dui:D002481;dis:Cellulitis;g:GJB2)(dui:D012878;dis:Skin Neoplasms;g:GJB2)(dui:D013543;dis:Sweat Gland Diseases;g:GJB2)(dui:D016575;dis:Hidradenitis;g:GJB2)(dui:D017192;dis:Skin Diseases, Bacterial;g:GJB2)(dui:D017497;dis:Hidradenitis Suppurativa;g:GJB2)		GO:0016328:GO:0048839:GO:1903763:GO:0032570:GO:0046677:GO:1905867:GO:0046697:GO:0005793:GO:0044752:GO:0005921:GO:0007605:GO:0005887:GO:0032526:GO:0002931:GO:0005922:GO:0071377:GO:0005509:GO:1990349:GO:0097449:GO:0005829:GO:0042802:GO:0055085:GO:0007267:GO:0005243:GO:0007568:GO:0005886:GO:0005515:GO:0048471:GO:0044297:GO:0010644:GO:0032355:GO:0016264:GO:0034599:GO:0032496:GO:0071549	121011	PF00029	0.67														M	
chr13:20222791	INDEL	AT	1	AT/A	PASS	1.2042038184717625e-29	289.193		395	AT=138,A=257	AT=0.3494,A=0.6506	65.06	34.94	heterozygous	1		7		GJB6	NM_001110220.2	GJB6:exonic:NM_001110220.2	frameshiftDeletion	ATC	4	p.Asn230IlefsTer7	c.689delA				A	GMAF=6.0E-4:AMAF=0.0:EMAF=0.001					rs398124237		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:GJB6)(dui:NBS2;dis:Core Conditions;g:GJB6)(dui:NBS14;dis:Other Disorder;g:GJB6)(dui:NBS75;dis:Hearing Loss;g:GJB6)(dui:D009422;dis:Nervous System Diseases;g:GJB6)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:GJB6)(dui:D012871;dis:Skin Diseases;g:GJB6)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:GJB6)(dui:D030342;dis:Genetic Diseases, Inborn;g:GJB6)(dui:D000013;dis:Congenital Abnormalities;g:GJB6)(dui:D000015;dis:Abnormalities, Multiple;g:GJB6)(dui:D012873;dis:Skin Diseases, Genetic;g:GJB6)(dui:D012868;dis:Skin Abnormalities;g:GJB6)(dui:D004476;dis:Ectodermal Dysplasia;g:GJB6)(dui:D009461;dis:Neurologic Manifestations;g:GJB6)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:GJB6)(dui:D004427;dis:Ear Diseases;g:GJB6)(dui:D006311;dis:Hearing Disorders;g:GJB6)(dui:D012678;dis:Sensation Disorders;g:GJB6)(dui:D034381;dis:Hearing Loss;g:GJB6)(dui:D006319;dis:Hearing Loss, Sensorineural;g:GJB6)(dui:D002493;dis:Central Nervous System Diseases;g:GJB6)(dui:D001927;dis:Brain Diseases;g:GJB6)(dui:D004827;dis:Epilepsy;g:GJB6)		GO:0048839:GO:1903763:GO:0008285:GO:0005921:GO:0007605:GO:0005922:GO:0071333:GO:0048487:GO:0006915:GO:1990349:GO:0005829:GO:0051602:GO:0035633:GO:0055085:GO:0007267:GO:0005243:GO:0005884:GO:0007568:GO:0008017:GO:0051015:GO:0005515:GO:0042471:GO:0010644:GO:0016021:GO:0016264:GO:0030054:GO:0032496:GO:0016324	604418	PF00029	-0.6,2.5														M	
chr13:100268802	SNV	A	1	G/G	PASS	0.0	3645.5		398	A=11,G=387	A=0.0276,G=0.9724	97.24	2.760000000000005	homozygous	1	0.084	1		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2										GMAF=0.0825:AMAF=0.2419:EMAF=8.0E-4			Benign		rs4306370		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	-0.76														M	
chr13:100368441	SNV	A	1	A/G	PASS	6.324118513762223e-101	1001.99		400	A=190,G=210	A=0.475,G=0.525	52.50	47.5	heterozygous	1	0.447	1		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2										GMAF=0.3177:AMAF=0.4921:EMAF=0.2284			Benign		rs9518061		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	2.28														M	
chr15:40405996	INDEL	GCCCCAAGGCCTCCTTCCTGCCTGGT	25	GCCCCAAGGCCTCCTTCCTGCCTGGT/G	PASS	7.481695005111461e-78	771.26		386	GCCCCAAGGCCTCCTTCCTGCCTGGT=204,G=182	GCCCCAAGGCCTCCTTCCTGCCTGGT=0.5285,G=0.4715	47.15	52.85	heterozygous	1	0.0	4		IVD	NR_148925.2	IVD:exonic_nc:NR_148925.2			1							GMAF=0.0583:AMAF=0.0209:EMAF=0.0776					rs776474354:rs373206450:rs1595751032:rs1361784904:rs761343713:rs1293826929:rs551337019:rs148239901:rs906489051:rs1357668930:rs1046280910:rs1323472436:rs1433088894:rs769380776:rs1217174067:rs1555402915:rs1555402927		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		1.31,-0.04,-0.08,-0.03,-2.28,-0.33,0.47,0.68,2.57,-0.06,0.65,0.28,-0.35,-1.14,-0.07,-0.66,1.27,0.64,-1.36,-0.64,-0.18,-3.46,-1.35,-0.03,0.87,-1.07														M	
chr15:40407739	SNV	T	1	C/C	PASS	0.0	3935.99		396	T=0,C=396	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.352	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2										GMAF=0.4044:AMAF=0.485:EMAF=0.3478			Benign		rs2289331		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		-1.6														M	
chr15:40407823	SNV	C	1	C/T	PASS	5.611771769773129e-89	882.509		396	C=199,T=197	C=0.5025,T=0.4975	49.75	50.25	heterozygous	1	0.473	2		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2															rs10518693:rs1566932254:rs1219352520		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.04														M	
chr15:40410915	SNV	A	1	A/G	PASS	1.888426125223435e-65	647.239		286	A=143,G=143	A=0.5,G=0.5	50.00	50.0	heterozygous	1	0.044	3		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2															rs8033938		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.32														M	
chr15:40411410	SNV	A	1	G/G	PASS	0.0	3921.24		393	A=0,G=393	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.022	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2													Benign		rs4924466		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.1														M	
chr15:40412906	SNV	A	1	G/G	PASS	0.0	3991.02		399	A=0,G=399	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.317	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2															rs2289330		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.42														M	
chr15:40412960	SNV	T	1	T/C	PASS	4.8361526430204343e-91	903.155		400	T=200,C=200	T=0.5,C=0.5	50.00	50.0	heterozygous	1	0.466	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2										GMAF=0.3293:AMAF=0.2031:EMAF=0.394			Benign		rs2289329		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.94														M	
chr15:40416223	SNV	A	1	G/G	PASS	0.0	3992.92		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.368	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2										GMAF=0.4227:AMAF=0.4324:EMAF=0.3485			Benign		rs11070270		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.49														M	
chr15:40416445	SNV	C	1	C/T	PASS	7.350214276467985e-48	471.337		224	C=116,T=108	C=0.5179,T=0.4821	48.21	51.79	heterozygous	1	0.043	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2															rs112366697		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.14														M	
chr15:40416502	SNV	C	1	C/T	PASS	2.0706180713346528e-41	406.839		210	C=113,T=97	C=0.5381,T=0.4619	46.19	53.81	heterozygous	1	0.043	2		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2															rs111540938		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.44														M	
chr15:76226005	INDEL	C	5	CCCTTA/CCCTTA	PASS	1.422328787122885e-286	2858.47		295	C=1,CCCTTA=294	C=0.0034,CCCTTA=0.9966	99.66	0.3400000000000034	homozygous	1	0.031	2		ETFA	NM_000126.4	ETFA:intronic:NM_000126.4	unknown			p.?	c.883-77_883-76insTAAGG				CCCTTA						rs11281932:rs112972949		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFA)(dui:NBS3;dis:Secondary Conditions;g:ETFA)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFA)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFA)(dui:D008659;dis:Metabolic Diseases;g:ETFA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFA)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFA)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFA)(dui:D028361;dis:Mitochondrial Diseases;g:ETFA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFA)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFA)(dui:D009140;dis:Musculoskeletal Diseases;g:ETFA)(dui:D007592;dis:Joint Diseases;g:ETFA)(dui:D012216;dis:Rheumatic Diseases;g:ETFA)(dui:D001168;dis:Arthritis;g:ETFA)(dui:D009369;dis:Neoplasms;g:ETFA)(dui:D009370;dis:Neoplasms by Histologic Type;g:ETFA)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:ETFA)(dui:D004066;dis:Digestive System Diseases;g:ETFA)(dui:D009371;dis:Neoplasms by Site;g:ETFA)(dui:D008107;dis:Liver Diseases;g:ETFA)(dui:D002277;dis:Carcinoma;g:ETFA)(dui:D000230;dis:Adenocarcinoma;g:ETFA)(dui:D004067;dis:Digestive System Neoplasms;g:ETFA)(dui:D008113;dis:Liver Neoplasms;g:ETFA)(dui:D010003;dis:Osteoarthritis;g:ETFA)(dui:D006528;dis:Carcinoma, Hepatocellular;g:ETFA)		GO:0033539:GO:0005515:GO:0005759:GO:0016491:GO:0050660:GO:0009055:GO:0005739:GO:0022904	608053	PF00766:PF01012	0.16														M	
chr15:76231430	SNV	T	1	T/C	PASS	2.4338846965042127e-93	926.137		399	T=197,C=202	T=0.4937,C=0.5063	50.63	49.37	heterozygous	1	0.047	1		ETFA	NM_000126.4	ETFA:intronic:NM_000126.4	unknown			p.?	c.817-32A>G				C	GMAF=0.0776:AMAF=0.0612:EMAF=0.086					rs62030234		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFA)(dui:NBS3;dis:Secondary Conditions;g:ETFA)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFA)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFA)(dui:D008659;dis:Metabolic Diseases;g:ETFA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFA)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFA)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFA)(dui:D028361;dis:Mitochondrial Diseases;g:ETFA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFA)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFA)(dui:D009140;dis:Musculoskeletal Diseases;g:ETFA)(dui:D007592;dis:Joint Diseases;g:ETFA)(dui:D012216;dis:Rheumatic Diseases;g:ETFA)(dui:D001168;dis:Arthritis;g:ETFA)(dui:D009369;dis:Neoplasms;g:ETFA)(dui:D009370;dis:Neoplasms by Histologic Type;g:ETFA)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:ETFA)(dui:D004066;dis:Digestive System Diseases;g:ETFA)(dui:D009371;dis:Neoplasms by Site;g:ETFA)(dui:D008107;dis:Liver Diseases;g:ETFA)(dui:D002277;dis:Carcinoma;g:ETFA)(dui:D000230;dis:Adenocarcinoma;g:ETFA)(dui:D004067;dis:Digestive System Neoplasms;g:ETFA)(dui:D008113;dis:Liver Neoplasms;g:ETFA)(dui:D010003;dis:Osteoarthritis;g:ETFA)(dui:D006528;dis:Carcinoma, Hepatocellular;g:ETFA)		GO:0033539:GO:0005515:GO:0005759:GO:0016491:GO:0050660:GO:0009055:GO:0005739:GO:0022904	608053	PF00766:PF01012	-0.53														M	
chr15:80152950	SNV	G	1	G/C	PASS	1.3816562311673273e-52	518.596		164	G=68,C=96	G=0.4146,C=0.5854	58.54	41.46	heterozygous	1	0.186	5		FAH	NM_000137.4	FAH:upstream:NM_000137.4	unknown			p.?	c.-105G>C				C				Benign		rs112474268		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-2.77														M	
chr15:80153170	INDEL	A	1	A/AG	PASS	6.311026445054071e-17	161.999		218	A=114,AG=104	A=0.5229,AG=0.4771	47.71	52.29	heterozygous	1	0.352	3		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.81+35_81+36insG				AG	GMAF=0.2324:AMAF=0.4252:EMAF=0.1328			Benign		rs1595888567:rs1465203494:rs1567112918:rs60184934:rs534453827:rs757176902		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.07														M	
chr15:80153209	INDEL	AGTGGA	5	AGTGGA/A	PASS	2.4104603938084325e-19	186.179		157	AGTGGA=102,A=55	AGTGGA=0.6497,A=0.3503	35.03	64.97	heterozygous	1	0.0	1		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.81+75_81+79delGTGGA				A						rs1567112946:rs534184772:rs1361931262:rs1316986199:rs867498731:rs1341663234		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-1.35,0.39,0.16,0.21,0.17,-0.94														M	
chr15:80158047	SNV	G	1	G/A	PASS	1.298972628897828e-86	858.864		335	G=157,A=178	G=0.4687,A=0.5313	53.13	46.87	heterozygous	1	0.493	1		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.82-13G>A				A	GMAF=0.4463:AMAF=0.3221:EMAF=0.49			Benign		rs1370275		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-4.7														M	
chr15:80159733	SNV	T	1	C/C	PASS	6.426877173170089e-112	1111.92		130	T=7,C=123	T=0.0538,C=0.9462	94.62	5.3799999999999955	homozygous	1	0.367	6		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.193-23T>C				C	GMAF=0.3974:AMAF=0.3865:EMAF=0.4029			Benign		rs1370274		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	0.14														M	
chr15:80159830	SNV	G	1	G/C	PASS	9.84691071376934e-45	440.067		162	G=74,C=88	G=0.4568,C=0.5432	54.32	45.68	heterozygous	1	0.06	1		FAH	NM_000137.4	FAH:exonic:NM_000137.4	synonymous	CTC	3	p.Leu89=	c.267G>C				C	GMAF=0.0822:AMAF=0.0774:EMAF=0.0847	0.74		Benign	3999621	rs33929922		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	1.56														M	
chr15:80159926	SNV	G	1	A/A	PASS	5.223961889991411e-171	1702.82		173	G=0,A=173	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.36	2		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.314+49G>A				A	GMAF=0.3919:AMAF=0.3684:EMAF=0.404			Benign		rs1370273:rs1404883356		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.57														M	
chr15:80168182	SNV	A	1	G/G	PASS	0.0	3983.57		398	A=0,G=398	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.221	1		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.553+33A>G				G	GMAF=0.273:AMAF=0.2453:EMAF=0.2871			Benign		rs1545119		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	0.21														M	
chr15:80172327	SNV	A	1	A/G	PASS	2.565074598777443e-94	935.909		399	A=196,G=203	A=0.4912,G=0.5088	50.88	49.12	heterozygous	1	0.236	1		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.706+79A>G				G						rs7180031		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.7														M	
chr15:80175284	SNV	G	1	G/T	PASS	2.397728469963836e-76	756.202		400	G=216,T=184	G=0.54,T=0.46	46.00	54.0	heterozygous	1	0.447	3		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.913+193G>T				T						rs1863768		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.01														M	
chr15:80180089	SNV	C	1	C/A	PASS	8.623826291517602e-98	970.643		397	C=191,A=206	C=0.4811,A=0.5189	51.89	48.11	heterozygous	1	0.33	2		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.961-35C>A				A	GMAF=0.406:AMAF=0.4737:EMAF=0.3713			Benign		rs2043691		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-1.01														M	
chr15:80186247	MNV	ACCCC	5	ACCCC/CTTTG	PASS	7.903145908644514e-73	721.022		387	ACCCC=210,CTTTG=177	ACCCC=0.5426,CTTTG=0.4574	45.74	54.26	0	1	0.112	1		FAH	NM_000137.4	FAH:utr_3:NM_000137.4	unknown		14	p.?	c.*38ACCCC>CTTTG				CTTTG						rs3210172:rs1049181:rs374309326:rs751787251:rs370537299:rs199626920:rs377100715:rs369845634:rs386785740		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-1.95,0.27,0.04,0.13,0.06														M	
chr15:80186257	INDEL	AC	1	AC/A	PASS	1.2316859857363514e-33	329.095		398	AC=210,A=188	AC=0.5276,A=0.4724	47.24	52.76	heterozygous	1	0.112	3		FAH	NM_000137.4	FAH:utr_3:NM_000137.4	unknown		14	p.?	c.*48AC>A				A	GMAF=0.1042:AMAF=0.0643:EMAF=0.1249			Likely benign		rs200464452:rs755736456:rs749985438		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-1.97,0.39														M	
chr15:80186303	SNV	T	1	T/C	PASS	8.048222975884946e-82	810.943		400	T=210,C=190	T=0.525,C=0.475	47.50	52.5	heterozygous	1	0.113	2		FAH	NM_000137.4	FAH:utr_3:NM_000137.4	unknown		14	p.?	c.*94T>C				C				Benign		rs1049194		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.25														M	
chr16:71570009	SNV	C	1	C/A	PASS	3.148473193387334e-68	675.019		290	C=143,A=147	C=0.4931,A=0.5069	50.69	49.31	heterozygous	1	0.433	5		TAT|TAT-AS1	NM_000353.3|NR_103851.1	TAT:intronic:NM_000353.3|TAT-AS1:intronic_nc:NR_103851.1	unknown|	|	|	p.?|	c.1042-72G>T|	|	|	|	A|						rs172650:rs1413052063		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TAT)(dui:NBS3;dis:Secondary Conditions;g:TAT)(dui:NBS6;dis:Amino Acid Disorder;g:TAT)(dui:NBS37;dis:Tyrosinemia type II;g:TAT)(dui:NBS38;dis:Tyrosinemia type III;g:TAT)(dui:D009422;dis:Nervous System Diseases;g:TAT)(dui:D002493;dis:Central Nervous System Diseases;g:TAT)(dui:D001927;dis:Brain Diseases;g:TAT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:TAT)(dui:D008659;dis:Metabolic Diseases;g:TAT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TAT)(dui:D030342;dis:Genetic Diseases, Inborn;g:TAT)(dui:D008661;dis:Metabolism, Inborn Errors;g:TAT)(dui:D001928;dis:Brain Diseases, Metabolic;g:TAT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:TAT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:TAT)(dui:D020176;dis:Tyrosinemias;g:TAT)	Pyridoxal phosphate:Tyrosine:Glutamic acid:Phenylalanine	GO:0030170:GO:0042802:GO:0046689:GO:0006572:GO:0009058:GO:0005575:GO:0006103:GO:0006979:GO:0006536:GO:0005515:GO:0006559:GO:0004838:GO:0005739:GO:0051384:GO:0005829:GO:0016597	613018	PF07706:PF00155:PF00266	0.63														M	
chr16:71573481	SNV	T	1	T/G	PASS	3.3511973196770638e-90	894.748		400	T=201,G=199	T=0.5025,G=0.4975	49.75	50.25	heterozygous	1	0.414	1		TAT	NM_000353.3	TAT:intronic:NM_000353.3	unknown			p.?	c.408+58A>C				G	GMAF=0.3121:AMAF=0.229:EMAF=0.3482					rs2432520		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TAT)(dui:NBS3;dis:Secondary Conditions;g:TAT)(dui:NBS6;dis:Amino Acid Disorder;g:TAT)(dui:NBS37;dis:Tyrosinemia type II;g:TAT)(dui:NBS38;dis:Tyrosinemia type III;g:TAT)(dui:D009422;dis:Nervous System Diseases;g:TAT)(dui:D002493;dis:Central Nervous System Diseases;g:TAT)(dui:D001927;dis:Brain Diseases;g:TAT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:TAT)(dui:D008659;dis:Metabolic Diseases;g:TAT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TAT)(dui:D030342;dis:Genetic Diseases, Inborn;g:TAT)(dui:D008661;dis:Metabolism, Inborn Errors;g:TAT)(dui:D001928;dis:Brain Diseases, Metabolic;g:TAT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:TAT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:TAT)(dui:D020176;dis:Tyrosinemias;g:TAT)	Pyridoxal phosphate:Tyrosine:Glutamic acid:Phenylalanine	GO:0030170:GO:0042802:GO:0046689:GO:0006572:GO:0009058:GO:0005575:GO:0006103:GO:0006979:GO:0006536:GO:0005515:GO:0006559:GO:0004838:GO:0005739:GO:0051384:GO:0005829:GO:0016597	613018	PF07706:PF00155:PF00266	0.9														M	
chr17:7221421	INDEL	ACTGCCCTAGGTCAGGAA	17	ACTGCCCTAGGTCAGGAA/A	PASS	8.466423722659152e-65	640.723		345	ACTGCCCTAGGTCAGGAA=188,A=157	ACTGCCCTAGGTCAGGAA=0.5449,A=0.4551	45.51	54.49	heterozygous	1	0.002	1		ACADVL	NM_000018.4	ACADVL:intronic:NM_000018.4	unknown			p.?	c.478-116_478-100delCTGCCCTAGGTCAGGAA				A						rs750835287:rs1567562754:rs80162838:rs78100429:rs535609436:rs35999860:rs147519793:rs1416225920:rs1184230081:rs1322109465:rs386795011:rs374828700:rs907034423:rs7503586:rs370388543:rs201760717:rs1031535036		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADVL)(dui:NBS2;dis:Core Conditions;g:ACADVL)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADVL)(dui:NBS52;dis:Very long-chain acyl-CoA dehydrogenase deficiency;g:ACADVL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADVL)(dui:D008659;dis:Metabolic Diseases;g:ACADVL)(dui:D009422;dis:Nervous System Diseases;g:ACADVL)(dui:D009140;dis:Musculoskeletal Diseases;g:ACADVL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADVL)(dui:D009135;dis:Muscular Diseases;g:ACADVL)(dui:D009468;dis:Neuromuscular Diseases;g:ACADVL)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADVL)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADVL)(dui:D028361;dis:Mitochondrial Diseases;g:ACADVL)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADVL)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADVL)		GO:0036498:GO:0005730:GO:0004466:GO:0005654:GO:0009409:GO:0006635:GO:0033539:GO:0000062:GO:0046322:GO:0005829:GO:0031314:GO:0045717:GO:0042802:GO:0015980:GO:0042645:GO:0090181:GO:0003995:GO:0030855:GO:0005515:GO:0031966:GO:0005759:GO:0050660:GO:0001659:GO:0005739:GO:0017099	609575	PF02771:PF02770:PF00441:PF08028	-0.78,0.12,0.1,-0.17,-0.72,-1.03,-0.35,-0.01,-1.94,-0.18,1.36,-1.92,-0.66,0.83,-0.02,0.03,-0.03,-0.45														M	
chr17:7221449	SNV	T	1	T/C	PASS	2.7108157484272076e-83	825.669		392	T=202,C=190	T=0.5153,C=0.4847	48.47	51.53	heterozygous	1	0.478	1		ACADVL	NM_000018.4	ACADVL:intronic:NM_000018.4	unknown			p.?	c.478-89T>C				C						rs77493353:rs1416225920:rs9646410:rs386795011:rs386795012:rs374828700:rs1567562793		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADVL)(dui:NBS2;dis:Core Conditions;g:ACADVL)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADVL)(dui:NBS52;dis:Very long-chain acyl-CoA dehydrogenase deficiency;g:ACADVL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADVL)(dui:D008659;dis:Metabolic Diseases;g:ACADVL)(dui:D009422;dis:Nervous System Diseases;g:ACADVL)(dui:D009140;dis:Musculoskeletal Diseases;g:ACADVL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADVL)(dui:D009135;dis:Muscular Diseases;g:ACADVL)(dui:D009468;dis:Neuromuscular Diseases;g:ACADVL)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADVL)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADVL)(dui:D028361;dis:Mitochondrial Diseases;g:ACADVL)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADVL)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADVL)		GO:0036498:GO:0005730:GO:0004466:GO:0005654:GO:0009409:GO:0006635:GO:0033539:GO:0000062:GO:0046322:GO:0005829:GO:0031314:GO:0045717:GO:0042802:GO:0015980:GO:0042645:GO:0090181:GO:0003995:GO:0030855:GO:0005515:GO:0031966:GO:0005759:GO:0050660:GO:0001659:GO:0005739:GO:0017099	609575	PF02771:PF02770:PF00441:PF08028	0.0														M	
chr17:7224399	SNV	T	1	T/C	PASS	5.843862649556606e-87	862.333		398	T=203,C=195	T=0.5101,C=0.4899	49.00	51.0	heterozygous	1	0.48	1		ACADVL|DVL2	NM_000018.4|NM_004422.3	ACADVL:intronic:NM_000018.4|DVL2:downstream:NM_004422.3	unknown|unknown	|	|	p.?|p.?	c.1605+6T>C|c.*1466A>G	|	|	|	C|C	GMAF=0.4383:AMAF=0.4362:EMAF=0.3739	0.07		Benign	7228542	rs17671352:rs1064795676		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADVL)(dui:NBS2;dis:Core Conditions;g:ACADVL)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADVL)(dui:NBS52;dis:Very long-chain acyl-CoA dehydrogenase deficiency;g:ACADVL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADVL)(dui:D008659;dis:Metabolic Diseases;g:ACADVL)(dui:D009422;dis:Nervous System Diseases;g:ACADVL)(dui:D009140;dis:Musculoskeletal Diseases;g:ACADVL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADVL)(dui:D009135;dis:Muscular Diseases;g:ACADVL)(dui:D009468;dis:Neuromuscular Diseases;g:ACADVL)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADVL)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADVL)(dui:D028361;dis:Mitochondrial Diseases;g:ACADVL)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADVL)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADVL)		GO:0036498:GO:0016328:GO:0043507:GO:0016604:GO:0090179:GO:0061098:GO:0022007:GO:0051091:GO:0043621:GO:0007379:GO:0043547:GO:0004466:GO:0006635:GO:0033539:GO:0005109:GO:0045177:GO:0000062:GO:0048365:GO:0005829:GO:0031314:GO:0019901:GO:0019904:GO:0090103:GO:0150012:GO:0045334:GO:0090181:GO:0030855:GO:0005634:GO:0005515:GO:0005759:GO:0017099:GO:0034613:GO:0003151:GO:0005730:GO:0045944:GO:0005654:GO:0009409:GO:0007507:GO:0001843:GO:0044340:GO:0046322:GO:0031410:GO:0060070:GO:0060071:GO:0016235:GO:0045717:GO:0061024:GO:0042802:GO:0015980:GO:0006355:GO:1904886:GO:0042645:GO:0003995:GO:0090090:GO:0031966:GO:0050660:GO:0005737:GO:0001659:GO:0005739:GO:0001934:GO:0035329:GO:0030674:GO:0035567	609575:602151	PF02771:PF02770:PF00441:PF08028	-0.25														M	
chr19:12899706	SNV	A	1	G/G	PASS	0.0	3994.16		399	A=0,G=399	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.28	1		GCDH|SYCE2	NR_102317.1|NM_001105578.2	GCDH:exonic_nc:NR_102317.1|SYCE2:intronic:NM_001105578.2	|unknown	|	11|	|p.?	|c.612+298T>C	|	|	|	|G	GMAF=0.3611:AMAF=0.1756:EMAF=0.4546	0.11		Benign	7218541	rs8012		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:GCDH)(dui:NBS2;dis:Core Conditions;g:GCDH)(dui:NBS9;dis:Organic Acid Condition;g:GCDH)(dui:NBS49;dis:Glutaric acidemia type I;g:GCDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:GCDH)(dui:D008659;dis:Metabolic Diseases;g:GCDH)(dui:D009422;dis:Nervous System Diseases;g:GCDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:GCDH)(dui:D002493;dis:Central Nervous System Diseases;g:GCDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:GCDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:GCDH)(dui:D001927;dis:Brain Diseases;g:GCDH)(dui:D001928;dis:Brain Diseases, Metabolic;g:GCDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:GCDH)	S-4-Nitrobutyryl-CoA:Flavin adenine dinucleotide	GO:0051301:GO:0005515:GO:0007130:GO:0000801:GO:0005654	611487:608801	PF02771:PF02770:PF01442:PF00441:PF08028	0.32														M	
chr19:41397766	SNV	A	1	G/G	PASS	0.0	3966.36		400	A=1,G=399	A=0.0025,G=0.9975	99.75	0.25	homozygous	1	0.418	3		EXOSC5|BCKDHA	NM_020158.4|NM_001164783.2	EXOSC5:upstream:NM_020158.4|BCKDHA:upstream:NM_001164783.2	unknown|unknown	|	|	p.?|p.?	c.-438T>C|c.-62A>G	|	|	|	G|G						rs892044		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)(dui:D009369;dis:Neoplasms;g:EXOSC5)(dui:D009371;dis:Neoplasms by Site;g:EXOSC5)(dui:D004066;dis:Digestive System Diseases;g:EXOSC5)(dui:D004067;dis:Digestive System Neoplasms;g:EXOSC5)(dui:D005767;dis:Gastrointestinal Diseases;g:EXOSC5)(dui:D005770;dis:Gastrointestinal Neoplasms;g:EXOSC5)(dui:D013272;dis:Stomach Diseases;g:EXOSC5)(dui:D013274;dis:Stomach Neoplasms;g:EXOSC5)		GO:0034475:GO:0043928:GO:0045006:GO:0043488:GO:0006364:GO:0005730:GO:0000178:GO:0005654:GO:0003863:GO:0071051:GO:0003723:GO:0005947:GO:0003826:GO:0016075:GO:0005829:GO:0051607:GO:0034427:GO:0016831:GO:0090503:GO:0009083:GO:0004532:GO:0000177:GO:0000176:GO:0000175:GO:0005515:GO:0005759:GO:0046872:GO:0005737:GO:0005739:GO:0035327:GO:0071028:GO:0055114	606492:608348		0.08														M	
chr19:41397770	SNV	A	1	G/G	PASS	0.0	3999.17		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.02	1		EXOSC5|BCKDHA	NM_020158.4|NM_001164783.2	EXOSC5:upstream:NM_020158.4|BCKDHA:upstream:NM_001164783.2	unknown|unknown	|	|	p.?|p.?	c.-442T>C|c.-58A>G	|	|	|	G|G						rs892043		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)(dui:D009369;dis:Neoplasms;g:EXOSC5)(dui:D009371;dis:Neoplasms by Site;g:EXOSC5)(dui:D004066;dis:Digestive System Diseases;g:EXOSC5)(dui:D004067;dis:Digestive System Neoplasms;g:EXOSC5)(dui:D005767;dis:Gastrointestinal Diseases;g:EXOSC5)(dui:D005770;dis:Gastrointestinal Neoplasms;g:EXOSC5)(dui:D013272;dis:Stomach Diseases;g:EXOSC5)(dui:D013274;dis:Stomach Neoplasms;g:EXOSC5)		GO:0034475:GO:0043928:GO:0045006:GO:0043488:GO:0006364:GO:0005730:GO:0000178:GO:0005654:GO:0003863:GO:0071051:GO:0003723:GO:0005947:GO:0003826:GO:0016075:GO:0005829:GO:0051607:GO:0034427:GO:0016831:GO:0090503:GO:0009083:GO:0004532:GO:0000177:GO:0000176:GO:0000175:GO:0005515:GO:0005759:GO:0046872:GO:0005737:GO:0005739:GO:0035327:GO:0071028:GO:0055114	606492:608348		0.12														M	
chr19:41414039	SNV	A	1	C/C	PASS	0.0	3990.19		399	A=0,C=399	A=0.0,C=1.0	100.00	0.0	homozygous	1	0.384	1		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.376-10A>C				C	GMAF=0.3239:AMAF=0.1902:EMAF=0.3924	0.01		Benign	4000746	rs3213861		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-0.51														M	
chr19:41422431	SNV	T	1	C/C	PASS	0.0	3982.4		400	T=0,C=400	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.382	1		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.853+61T>C				C						rs284651		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-2.12														M	
chr19:41422747	SNV	C	1	T/T	PASS	0.0	3923.24		400	C=2,T=398	C=0.005,T=0.995	99.50	0.5	homozygous	1	0.384	2		BCKDHA	NM_001164783.2	BCKDHA:exonic:NM_001164783.2	synonymous	TTT	7	p.Phe323=	c.969C>T				T	GMAF=0.3239:AMAF=0.1902:EMAF=0.3924	0.92		Benign	3933055	rs284652:rs112312448		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	2.87														M	
chr19:41422796	SNV	C	1	T/T	PASS	0.0	3588.42		394	C=12,T=382	C=0.0305,T=0.9695	96.95	3.049999999999997	homozygous	1	0.257	5		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.992+26C>T				T	GMAF=0.3824:AMAF=0.264:EMAF=0.4431			Benign/Likely benign		rs284653		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-0.25														M	
chr19:41422819	SNV	G	1	A/A	PASS	0.0	3967.04		400	G=1,A=399	G=0.0025,A=0.9975	99.75	0.25	homozygous	1	0.414	1		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.992+49G>A				A	GMAF=0.3565:AMAF=0.2855:EMAF=0.3929			Benign/Likely benign		rs284654		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-1.91														M	
chr19:41422860	SNV	C	1	T/T	PASS	0.0	3936.49		400	C=2,T=398	C=0.005,T=0.995	99.50	0.5	homozygous	1	0.386	2		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.992+90C>T				T						rs284655		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	0.58														M	
chr19:41424491	SNV	A	1	G/G	PASS	0.0	3993.27		399	A=0,G=399	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.383	1		BCKDHA|B3GNT8	NM_001164783.2|NM_198540.2	BCKDHA:exonic:NM_001164783.2|B3GNT8:downstream:NM_198540.2	synonymous|unknown	CTG|	9|	p.Leu406=|p.?	c.1218A>G|c.*1094T>C	|	|	|	G|G	GMAF=0.323:AMAF=0.1895:EMAF=0.3914	0.15		Benign	7239888	rs4674		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0009083:GO:0016758:GO:0008375:GO:0006486:GO:0008532:GO:0000139:GO:0005794:GO:0008376:GO:0003863:GO:0005515:GO:0070062:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0016262:GO:0016021:GO:0055114:GO:0016266:GO:0030311:GO:0016831	615357:608348	PF00676	0.76														M	
chr19:45529583	SNV	G	1	G/C	PASS	2.2698648518837933e-62	616.44		398	G=231,C=167	G=0.5804,C=0.4196	41.96	58.04	heterozygous	1	0.309	4		OPA3																	rs12971437		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:OPA3)(dui:NBS3;dis:Secondary Conditions;g:OPA3)(dui:NBS4;dis:Organic Acid Condition;g:OPA3)(dui:NBS19;dis:3-Methylglutaconic aciduria;g:OPA3)(dui:D009422;dis:Nervous System Diseases;g:OPA3)(dui:D005128;dis:Eye Diseases;g:OPA3)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OPA3)(dui:D030342;dis:Genetic Diseases, Inborn;g:OPA3)(dui:D003389;dis:Cranial Nerve Diseases;g:OPA3)(dui:D009901;dis:Optic Nerve Diseases;g:OPA3)(dui:D019636;dis:Neurodegenerative Diseases;g:OPA3)(dui:D009896;dis:Optic Atrophy;g:OPA3)(dui:D020271;dis:Heredodegenerative Disorders, Nervous System;g:OPA3)(dui:D015785;dis:Eye Diseases, Hereditary;g:OPA3)(dui:D015418;dis:Optic Atrophies, Hereditary;g:OPA3)(dui:D007905;dis:Lens Diseases;g:OPA3)(dui:D002386;dis:Cataract;g:OPA3)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OPA3)(dui:D008659;dis:Metabolic Diseases;g:OPA3)(dui:D009461;dis:Neurologic Manifestations;g:OPA3)(dui:D000013;dis:Congenital Abnormalities;g:OPA3)(dui:D002493;dis:Central Nervous System Diseases;g:OPA3)(dui:D009421;dis:Nervous System Malformations;g:OPA3)(dui:D009468;dis:Neuromuscular Diseases;g:OPA3)(dui:D008661;dis:Metabolism, Inborn Errors;g:OPA3)(dui:D009069;dis:Movement Disorders;g:OPA3)(dui:D010523;dis:Peripheral Nervous System Diseases;g:OPA3)(dui:D015417;dis:Hereditary Sensory and Motor Neuropathy;g:OPA3)(dui:D020820;dis:Dyskinesias;g:OPA3)(dui:D002819;dis:Chorea;g:OPA3)(dui:D011115;dis:Polyneuropathies;g:OPA3)(dui:D015419;dis:Spastic Paraplegia, Hereditary;g:OPA3)			606580		-0.72														M	
chr19:45553823	SNV	A	1	G/G	PASS	0.0	3993.33		399	A=0,G=399	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.233	1		OPA3	NM_025136.4	OPA3:exonic:NM_025136.4	synonymous	GCC	2	p.Ala77=	c.231T>C				G	GMAF=0.3174:AMAF=0.2398:EMAF=0.3572	0.09		Benign	439792	rs3826860		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:OPA3)(dui:NBS3;dis:Secondary Conditions;g:OPA3)(dui:NBS4;dis:Organic Acid Condition;g:OPA3)(dui:NBS19;dis:3-Methylglutaconic aciduria;g:OPA3)(dui:D009422;dis:Nervous System Diseases;g:OPA3)(dui:D005128;dis:Eye Diseases;g:OPA3)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OPA3)(dui:D030342;dis:Genetic Diseases, Inborn;g:OPA3)(dui:D003389;dis:Cranial Nerve Diseases;g:OPA3)(dui:D009901;dis:Optic Nerve Diseases;g:OPA3)(dui:D019636;dis:Neurodegenerative Diseases;g:OPA3)(dui:D009896;dis:Optic Atrophy;g:OPA3)(dui:D020271;dis:Heredodegenerative Disorders, Nervous System;g:OPA3)(dui:D015785;dis:Eye Diseases, Hereditary;g:OPA3)(dui:D015418;dis:Optic Atrophies, Hereditary;g:OPA3)(dui:D007905;dis:Lens Diseases;g:OPA3)(dui:D002386;dis:Cataract;g:OPA3)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OPA3)(dui:D008659;dis:Metabolic Diseases;g:OPA3)(dui:D009461;dis:Neurologic Manifestations;g:OPA3)(dui:D000013;dis:Congenital Abnormalities;g:OPA3)(dui:D002493;dis:Central Nervous System Diseases;g:OPA3)(dui:D009421;dis:Nervous System Malformations;g:OPA3)(dui:D009468;dis:Neuromuscular Diseases;g:OPA3)(dui:D008661;dis:Metabolism, Inborn Errors;g:OPA3)(dui:D009069;dis:Movement Disorders;g:OPA3)(dui:D010523;dis:Peripheral Nervous System Diseases;g:OPA3)(dui:D015417;dis:Hereditary Sensory and Motor Neuropathy;g:OPA3)(dui:D020820;dis:Dyskinesias;g:OPA3)(dui:D002819;dis:Chorea;g:OPA3)(dui:D011115;dis:Polyneuropathies;g:OPA3)(dui:D015419;dis:Spastic Paraplegia, Hereditary;g:OPA3)		GO:0070584:GO:0005739:GO:0050905:GO:0045444:GO:0007601:GO:0019216:GO:0040008:GO:0050896:GO:0060348	606580	PF07047	-0.93														M	
chr19:51347036	SNV	G	1	G/A	PASS	9.130614352931676e-88	870.395		398	G=202,A=196	G=0.5075,A=0.4925	49.25	50.75	heterozygous	1	0.42	1		ETFB	NM_001985.3	ETFB:exonic:NM_001985.3	missense	ATG	5	p.Thr154Met	c.461C>T	0.01	0.98	81.0	A	GMAF=0.4582:AMAF=0.4911:EMAF=0.4413	0.94		Benign	3721676	rs1130426		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904	130410	PF01012	3.13														M	
chr19:51347148	SNV	T	1	T/C	PASS	6.258928639214535e-99	982.035		400	T=192,C=208	T=0.48,C=0.52	52.00	48.0	heterozygous	1	0.117	1		ETFB	NM_001985.3	ETFB:intronic:NM_001985.3	unknown			p.?	c.439-90A>G				C						rs8112687		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904	130410	PF01012	-1.71														M	
chr19:51347173	SNV	G	1	G/A	PASS	3.8663396210936004e-91	904.127		398	G=198,A=200	G=0.4975,A=0.5025	50.25	49.75	heterozygous	1	0.022	1		ETFB	NM_001985.3	ETFB:intronic:NM_001985.3	unknown			p.?	c.439-115C>T				A						rs74903528		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904	130410	PF01012	-1.02														M	
chr19:51347231	SNV	T	1	T/C	PASS	4.578255227916849e-72	713.393		400	T=221,C=179	T=0.5525,C=0.4475	44.75	55.25	heterozygous	1	0.456	5		ETFB	NM_001985.3	ETFB:intronic:NM_001985.3	unknown			p.?	c.439-173A>G				C				Benign		rs8112785		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904	130410	PF01012	-0.49														M	
chr19:51347252	SNV	C	1	C/T	PASS	2.960056495075816e-89	885.287		400	C=202,T=198	C=0.505,T=0.495	49.50	50.5	heterozygous	1	0.116	1		ETFB	NM_001985.3	ETFB:intronic:NM_001985.3	unknown			p.?	c.439-194G>A				T				Benign		rs8111973		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904	130410	PF01012	-0.6														M	
chr19:51366092	SNV	G	1	G/A	PASS	3.74714069514405e-97	964.263		399	G=193,A=206	G=0.4837,A=0.5163	51.63	48.37	heterozygous	1	0.366	2		ETFB	NM_001985.3	ETFB:intronic:NM_001985.3	unknown			p.?	c.57+178C>T				A						rs3786625		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904	130410	PF01012	0.73														M	
chrX:30308866	SNV	C	1	C/T	PASS	2.581665671701643e-89	885.881		370	C=180,T=190	C=0.4865,T=0.5135	51.35	48.65	heterozygous	1	0.477	2		NR0B1	NM_000475.5	NR0B1:exonic:NM_000475.5	synonymous	CGA	1	p.Arg166=	c.498G>A				T	GMAF=0.2828:AMAF=0.4339:EMAF=0.1968	0.08		Benign	3759465	rs2269345		(dui:D004700;dis:Endocrine System Diseases;g:NR0B1)(dui:D006058;dis:Gonadal Disorders;g:NR0B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:NR0B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:NR0B1)(dui:D052776;dis:Female Urogenital Diseases;g:NR0B1)(dui:D052801;dis:Male Urogenital Diseases;g:NR0B1)(dui:D000013;dis:Congenital Abnormalities;g:NR0B1)(dui:D014564;dis:Urogenital Abnormalities;g:NR0B1)(dui:D012734;dis:Disorders of Sex Development;g:NR0B1)(dui:D006059;dis:Gonadal Dysgenesis;g:NR0B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:NR0B1)(dui:D000307;dis:Adrenal Gland Diseases;g:NR0B1)(dui:D007006;dis:Hypogonadism;g:NR0B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:NR0B1)(dui:D008659;dis:Metabolic Diseases;g:NR0B1)(dui:D000309;dis:Adrenal Insufficiency;g:NR0B1)(dui:D058490;dis:46, XY Disorders of Sex Development;g:NR0B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:NR0B1)(dui:D040181;dis:Genetic Diseases, X-Linked;g:NR0B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:NR0B1)(dui:D011629;dis:Puberty, Precocious;g:NR0B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:NR0B1)(dui:D047808;dis:Adrenogenital Syndrome;g:NR0B1)(dui:D006061;dis:Gonadal Dysgenesis, 46,XY;g:NR0B1)	Dexamethasone:Dexamethasone acetate	GO:0008584:GO:0033144:GO:0016607:GO:0034451:GO:0008104:GO:0060008:GO:0021854:GO:0006367:GO:0005654:GO:0000122:GO:0003723:GO:0045892:GO:0043231:GO:0032448:GO:0035258:GO:0030325:GO:0010894:GO:0019904:GO:0042803:GO:0007283:GO:0043433:GO:0008134:GO:0021983:GO:0042788:GO:0005634:GO:0030238:GO:0005515:GO:0000790:GO:0008406:GO:0005737:GO:0050682:GO:0003714:GO:0016020:GO:0035902:GO:0033327	300473	PF14046:PF00104	0.48														M	
chrX:30309117	SNV	T	1	T/A	PASS	9.468474197117176e-05	40.2372		28	T=17,A=11	T=0.6071,A=0.3929	39.29	60.71	heterozygous	1		1		NR0B1	NM_000475.5	NR0B1:exonic:NM_000475.5	missense	TTG	1	p.Met83Leu	c.247A>T	0.12	0.005	15.0	A						rs1425603148		(dui:D004700;dis:Endocrine System Diseases;g:NR0B1)(dui:D006058;dis:Gonadal Disorders;g:NR0B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:NR0B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:NR0B1)(dui:D052776;dis:Female Urogenital Diseases;g:NR0B1)(dui:D052801;dis:Male Urogenital Diseases;g:NR0B1)(dui:D000013;dis:Congenital Abnormalities;g:NR0B1)(dui:D014564;dis:Urogenital Abnormalities;g:NR0B1)(dui:D012734;dis:Disorders of Sex Development;g:NR0B1)(dui:D006059;dis:Gonadal Dysgenesis;g:NR0B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:NR0B1)(dui:D000307;dis:Adrenal Gland Diseases;g:NR0B1)(dui:D007006;dis:Hypogonadism;g:NR0B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:NR0B1)(dui:D008659;dis:Metabolic Diseases;g:NR0B1)(dui:D000309;dis:Adrenal Insufficiency;g:NR0B1)(dui:D058490;dis:46, XY Disorders of Sex Development;g:NR0B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:NR0B1)(dui:D040181;dis:Genetic Diseases, X-Linked;g:NR0B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:NR0B1)(dui:D011629;dis:Puberty, Precocious;g:NR0B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:NR0B1)(dui:D047808;dis:Adrenogenital Syndrome;g:NR0B1)(dui:D006061;dis:Gonadal Dysgenesis, 46,XY;g:NR0B1)	Dexamethasone:Dexamethasone acetate	GO:0008584:GO:0033144:GO:0016607:GO:0034451:GO:0008104:GO:0060008:GO:0021854:GO:0006367:GO:0005654:GO:0000122:GO:0003723:GO:0045892:GO:0043231:GO:0032448:GO:0035258:GO:0030325:GO:0010894:GO:0019904:GO:0042803:GO:0007283:GO:0043433:GO:0008134:GO:0021983:GO:0042788:GO:0005634:GO:0030238:GO:0005515:GO:0000790:GO:0008406:GO:0005737:GO:0050682:GO:0003714:GO:0016020:GO:0035902:GO:0033327	300473	PF14046:PF00104	0.93														M	
chrX:154532293	SNV	G	1	G/A	PASS	1.2638630002312563e-40	398.983		246	G=141,A=105	G=0.5732,A=0.4268	42.68	57.32	hemizygous	1		2		G6PD	NM_001042351.3	G6PD:intronic:NM_001042351.3	unknown			p.?	c.1365-13C>T				A	GMAF=0.3923:AMAF=0.1523:EMAF=0.1327					rs2071429		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:G6PD)(dui:NBS3;dis:Secondary Conditions;g:G6PD)(dui:NBS39;dis:Hb carrier other than C,D,E,S,O-Arab;g:G6PD)(dui:NBS7;dis:Hemoglobin Disorder;g:G6PD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:G6PD)(dui:D030342;dis:Genetic Diseases, Inborn;g:G6PD)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:G6PD)(dui:D006402;dis:Hematologic Diseases;g:G6PD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:G6PD)(dui:D000740;dis:Anemia;g:G6PD)(dui:D008659;dis:Metabolic Diseases;g:G6PD)(dui:D000743;dis:Anemia, Hemolytic;g:G6PD)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:G6PD)(dui:D008661;dis:Metabolism, Inborn Errors;g:G6PD)(dui:D005955;dis:Glucosephosphate Dehydrogenase Deficiency;g:G6PD)(dui:D040181;dis:Genetic Diseases, X-Linked;g:G6PD)(dui:D002239;dis:Carbohydrate Metabolism, Inborn Errors;g:G6PD)(dui:D052801;dis:Male Urogenital Diseases;g:G6PD)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:G6PD)(dui:D014570;dis:Urologic Diseases;g:G6PD)(dui:D052776;dis:Female Urogenital Diseases;g:G6PD)(dui:D007674;dis:Kidney Diseases;g:G6PD)(dui:D004066;dis:Digestive System Diseases;g:G6PD)(dui:D002318;dis:Cardiovascular Diseases;g:G6PD)(dui:D014652;dis:Vascular Diseases;g:G6PD)(dui:D008107;dis:Liver Diseases;g:G6PD)(dui:D007154;dis:Immune System Diseases;g:G6PD)(dui:D007153;dis:Immunologic Deficiency Syndromes;g:G6PD)(dui:D007960;dis:Leukocyte Disorders;g:G6PD)(dui:D010585;dis:Phagocyte Bactericidal Dysfunction;g:G6PD)(dui:D009422;dis:Nervous System Diseases;g:G6PD)(dui:D002493;dis:Central Nervous System Diseases;g:G6PD)(dui:D001927;dis:Brain Diseases;g:G6PD)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:G6PD)(dui:D012871;dis:Skin Diseases;g:G6PD)(dui:D004700;dis:Endocrine System Diseases;g:G6PD)(dui:D044882;dis:Glucose Metabolism Disorders;g:G6PD)(dui:D005236;dis:Favism;g:G6PD)(dui:D000746;dis:Anemia, Hemolytic, Congenital Nonspherocytic;g:G6PD)(dui:D003920;dis:Diabetes Mellitus;g:G6PD)(dui:D002561;dis:Cerebrovascular Disorders;g:G6PD)(dui:D001928;dis:Brain Diseases, Metabolic;g:G6PD)(dui:D009748;dis:Nutrition Disorders;g:G6PD)(dui:D006105;dis:Granulomatous Disease, Chronic;g:G6PD)(dui:D052439;dis:Lipid Metabolism Disorders;g:G6PD)(dui:D002545;dis:Brain Ischemia;g:G6PD)(dui:D003872;dis:Dermatitis;g:G6PD)(dui:D017443;dis:Skin Diseases, Eczematous;g:G6PD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:G6PD)(dui:D003877;dis:Dermatitis, Contact;g:G6PD)(dui:D006946;dis:Hyperinsulinism;g:G6PD)(dui:D050171;dis:Dyslipidemias;g:G6PD)(dui:D051437;dis:Renal Insufficiency;g:G6PD)(dui:D006949;dis:Hyperlipidemias;g:G6PD)(dui:D007333;dis:Insulin Resistance;g:G6PD)(dui:D058186;dis:Acute Kidney Injury;g:G6PD)	Nicotinamide adenine dinucleotide phosphate:Glycolic acid:16-Bromoepiandrosterone:Artenimol	GO:0032094:GO:0010041:GO:0009051:GO:0061052:GO:0034451:GO:0006740:GO:0006006:GO:0043523:GO:0004345:GO:0009898:GO:0043249:GO:1904879:GO:0045471:GO:0070062:GO:0043231:GO:0006739:GO:0019322:GO:0005829:GO:0010734:GO:2000378:GO:0042802:GO:0042803:GO:0006098:GO:0006695:GO:0014070:GO:0021762:GO:0005536:GO:0005634:GO:0050661:GO:0051156:GO:0005515:GO:0005737:GO:0006749:GO:0006629:GO:0016020:GO:0034599:GO:0055114:GO:0046390	305900	PF00479:PF02781	-0.82														M	
chrX:154532439	SNV	A	1	G/G	PASS	0.0	4003.33		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	hemizygous	1		1		G6PD	NM_001042351.3	G6PD:exonic:NM_001042351.3	synonymous	TAC	11	p.Tyr437=	c.1311T>C				G	GMAF=0.1667:AMAF=0.2605:EMAF=0.1133			Benign		rs2230037		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:G6PD)(dui:NBS3;dis:Secondary Conditions;g:G6PD)(dui:NBS39;dis:Hb carrier other than C,D,E,S,O-Arab;g:G6PD)(dui:NBS7;dis:Hemoglobin Disorder;g:G6PD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:G6PD)(dui:D030342;dis:Genetic Diseases, Inborn;g:G6PD)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:G6PD)(dui:D006402;dis:Hematologic Diseases;g:G6PD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:G6PD)(dui:D000740;dis:Anemia;g:G6PD)(dui:D008659;dis:Metabolic Diseases;g:G6PD)(dui:D000743;dis:Anemia, Hemolytic;g:G6PD)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:G6PD)(dui:D008661;dis:Metabolism, Inborn Errors;g:G6PD)(dui:D005955;dis:Glucosephosphate Dehydrogenase Deficiency;g:G6PD)(dui:D040181;dis:Genetic Diseases, X-Linked;g:G6PD)(dui:D002239;dis:Carbohydrate Metabolism, Inborn Errors;g:G6PD)(dui:D052801;dis:Male Urogenital Diseases;g:G6PD)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:G6PD)(dui:D014570;dis:Urologic Diseases;g:G6PD)(dui:D052776;dis:Female Urogenital Diseases;g:G6PD)(dui:D007674;dis:Kidney Diseases;g:G6PD)(dui:D004066;dis:Digestive System Diseases;g:G6PD)(dui:D002318;dis:Cardiovascular Diseases;g:G6PD)(dui:D014652;dis:Vascular Diseases;g:G6PD)(dui:D008107;dis:Liver Diseases;g:G6PD)(dui:D007154;dis:Immune System Diseases;g:G6PD)(dui:D007153;dis:Immunologic Deficiency Syndromes;g:G6PD)(dui:D007960;dis:Leukocyte Disorders;g:G6PD)(dui:D010585;dis:Phagocyte Bactericidal Dysfunction;g:G6PD)(dui:D009422;dis:Nervous System Diseases;g:G6PD)(dui:D002493;dis:Central Nervous System Diseases;g:G6PD)(dui:D001927;dis:Brain Diseases;g:G6PD)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:G6PD)(dui:D012871;dis:Skin Diseases;g:G6PD)(dui:D004700;dis:Endocrine System Diseases;g:G6PD)(dui:D044882;dis:Glucose Metabolism Disorders;g:G6PD)(dui:D005236;dis:Favism;g:G6PD)(dui:D000746;dis:Anemia, Hemolytic, Congenital Nonspherocytic;g:G6PD)(dui:D003920;dis:Diabetes Mellitus;g:G6PD)(dui:D002561;dis:Cerebrovascular Disorders;g:G6PD)(dui:D001928;dis:Brain Diseases, Metabolic;g:G6PD)(dui:D009748;dis:Nutrition Disorders;g:G6PD)(dui:D006105;dis:Granulomatous Disease, Chronic;g:G6PD)(dui:D052439;dis:Lipid Metabolism Disorders;g:G6PD)(dui:D002545;dis:Brain Ischemia;g:G6PD)(dui:D003872;dis:Dermatitis;g:G6PD)(dui:D017443;dis:Skin Diseases, Eczematous;g:G6PD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:G6PD)(dui:D003877;dis:Dermatitis, Contact;g:G6PD)(dui:D006946;dis:Hyperinsulinism;g:G6PD)(dui:D050171;dis:Dyslipidemias;g:G6PD)(dui:D051437;dis:Renal Insufficiency;g:G6PD)(dui:D006949;dis:Hyperlipidemias;g:G6PD)(dui:D007333;dis:Insulin Resistance;g:G6PD)(dui:D058186;dis:Acute Kidney Injury;g:G6PD)	Nicotinamide adenine dinucleotide phosphate:Glycolic acid:16-Bromoepiandrosterone:Artenimol	GO:0032094:GO:0010041:GO:0009051:GO:0061052:GO:0034451:GO:0006740:GO:0006006:GO:0043523:GO:0004345:GO:0009898:GO:0043249:GO:1904879:GO:0045471:GO:0070062:GO:0043231:GO:0006739:GO:0019322:GO:0005829:GO:0010734:GO:2000378:GO:0042802:GO:0042803:GO:0006098:GO:0006695:GO:0014070:GO:0021762:GO:0005536:GO:0005634:GO:0050661:GO:0051156:GO:0005515:GO:0005737:GO:0006749:GO:0006629:GO:0016020:GO:0034599:GO:0055114:GO:0046390	305900	PF00479:PF02781	-2.64														M	
